Post on 06-Nov-2018
SUPPORTING INFORMATION
ANTIBIOTICS IN THE AQUATIC ENVIRONMENTS: A REVIEW OF THE EUROPEAN SCENARIO
Isabel T. Carvalho, Lúcia Santos*
LEPABE – Laboratory for Process Engineering, Environment, Biotechnology and
Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465,
Porto, Portugal
*Corresponding author: Tel.: +351 22 5081682, Fax: +351 22 508 1449, e-mail address:
lsantos@fe.up.pt
Table S1. Overview on the occurrence of antibiotics in European environmental aqueous matrices.Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Austria(Clara et al. 2005)
WWTPI; WWTPE (South-East)
Macrolide: ROX
Mean WWTPI: ROX=25-117
WWTPE: ROX=nd-69
SPE-HPLC-MS/MS ROX=10 ROX=20
Sulfonamide: SXZ
SXZ=nd-145 SXZ=nd-91 SXZ=20 SXZ=20
Belgium(Vergeynst et al. 2015)
WWTPI; WWTPE (Aalst; Schilde)
Amphenicol:CRP
Mean WWTPI:CRP=nd
WWTPE: CRP=nd
SPE-HPLC-(IT)HRMS
CRP=11-13 CRP=36-44
β-lactam: Penicillin AMX
AMX=nd AMX=nd AMX=9,023->25,000
AMX=>25,000
Diaminopyrimidine:TMT
TMT=111 TMT=34 TMT=28-59 TMT=93-197
Nitroimidazole:MND
MND=24 MND=nd MND=12-25 MND=40-84
Quinolones: FluoroquinolonesBSF; CPF; ERF; FMQ; GTF; LVF; MXF; NLA; SRFOther quinolonesFMQ; NLA
BSF=nd; CPF=342; ERF=nd; GTF=nd; LVF=413; MXF=317; SRF=nd; FMQ=nd; NLA=nd
BSF=nd; CPF=45; ERF=nd; FMQ=nd; GTF=nd; LVF=45; MXF=281; NLA=nd; SRF=nd
BSF=38-60; CPF=31-75; ERF=50-76; GTF=23-52; LVF=20-57; MXF=11-35; SRF=25-41; FMQ=59-159; NLA=86-198
BSF=128-201; CPF=102-250; ERF=166-252; GTF=76-175; LVF=68-189; MXF=35-118; SRF=83-137; FMQ=195-529; NLA=287-661
Sulfonamides:SDX; SMX; SMZ
SDX, SMX, SMZ=nd SDX=nd; SMX=54; SMZ=nd SDX=17-18; SMX=26-50; SMZ=46-73
SDX=55-61; SMX=86-168; SMZ=154-243
Tetracyclines:OXT; TTC
OXT=nd; TTC=1,371 OXT, TTC=nd OXT=592-1,119; TTC=161-295
OXT=1,974-3,731; TTC=539-985
Croatia(Senta et al. 2013)
WWTPI; WWTPE (Belisce; Bjelovar; Cakovec; Karlovac; Novi Zagreb; Osijek; Rijeka; Slavonski Brod; Sisak; Split; Varazdin; Vinkovci; Velika Gorica; Zadar; Zagreb)
Diaminopyrimidine:TMT
Min-max WWTPI:TMT=35-3,442
WWTPE: TMT=924-1,352
SPE-LC-(QqQ)MS/MS
na na
Macrolides:AZT; CTR; ERT; RXT
AZT=77-1,129; CTR=112-300; ERT=24-420; RXT=nd-50
AZT=38-784; CTR=25-113; ERT=15-163; RXT=nd
na na
Quinolones:FluoroquinolonesCPF ; ERF; NOF
CPF=nd-2,610; ERF=nd-16; NOF=nd-2,937
CPF=11-201; ERF=7-12; NOF=24-1,185
na na
Sulfonamides:SDZ; STA; SPD; SMZ; SMX
SDZ=2-132; SMX=210-11,555; SMZ=2-175; SPD =80-931; STA=1-4
SDZ=1-18; SMX=119-1,207; SMZ=nd; SPD=48-784; STA=nd
na na
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
(Babić et al. 2006)
WWTPE (pharmaceutical industry)
Diaminopyrimidine:TMT
WWTPE:TMT=nr
SPE-HPLC-DAD TMT=10,000 TMT=30,000
Quinolone:FluoroquinoloneERF
ERF=23,700 ERF=100,000 ERF=1,500
Sulfonamides:SDZ; SGD; SMZ
SDZ=111,400; SGD =211,100; SMZ=107,100->500,000 SDZ=10,000; SGD =40,000; SMZ=10,000
SDZ=20,000; SGD=60,000; SMZ=20,000
Tetracycline:OXT
OXT=nd OXT=10,000 OXT=30,000
Czech Republic(Golovko et al. 2014)
WWTPI; WWTPE (České Budějovice)
Diaminopyrimidine:TMT
Min-max WWTPI:TMT=120-530
WWTPE:TMT=83-440
SPE-LC-(QqQ)MS/MS
na TMT=3
Macrolides:AZT; CTR; ERT
AZT=14-510; CTR=310-3,090; ERT=20-300
AZT=8-220; CTR=210-2,310; ERT=30-350
na AZT=7; CTR=3; ERT=6
Quinolones:FluoroquinolonesCPF; LVF; NOF
CPF=80-860; LVF=5-69; NOF=130-1,330
CPF=8-190; LVF=4-18; NOF=20-250
na CPF=3; LVF=3; NOF=3
Sulfonamides:SMX; SPD
SMX=43-490; SPD =18-660 SMX=31-260; SPD=14-200 na SMX=5; SPD=3
(Tylová et al. 2013)
WWTPI; WWTPE (6 different localities)
Lincosamides:CDM; LCM
Min-max WWTPI:CDM=nd-150.7; LCM=nd-32.7
WWTPE:CDM=nd-102.1; LCM=nd-46.4
SPE-UHPLC-(TOF)MS
na CDM=4.36; LCM=4.23
Macrolides:CTR; ERT; RXT; TLS
CTR =79.0-1,287.9; ERT=nd-248.6; RXT=nd; TLS=nd
CTR =61.0-794.2; ERT=nd-204.2; RXT=nd; TLS=nd
na CTR =4.06; ERT=4.34; RXT=8.34; TLS=6.47
Quinolones:FluoroquinolonesCPF; ERF; NOF; OFX
CPF =nd-640.6; ERF=nd; NOF=nd-377.4; OFX=nd-485.0
CPF=nd-133.6; ERF=nd; NOF=nd 24.2-63.0; OFX=nd-283.0
na CPF =3.68; ERF=3.99; NOF=3.75; OFX=7.81
Sulfonamides:SDD; SDM; SDZ; SMX; STA
SDD=nd-177.1; SDM=nd; SDZ=ndSMX=nd-796.2; STA =nd
SDD=nd; SDM=nd; SDZ=nd; SMX=nd-681.1;STA=nd
na SDD=8.43; SDM=8.80; SDZ=10.43; SMX=8.68; STA=8.75
Tetracyclines:CTC; DXC; OXT; TTC
CTC, DXC, OXT, TTC=nd CTC, DXC, OXT, TTC=nd na CTC=18.07; DXC=17.33; OXT=8.22; TTC=8.27
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
(Seifrtová et al. 2010)
HWWTPI; HWWTPE (University Hospital, Hradec Králové); RW (Elbe River, Hradec Králové)
Quinolones:FluoroquinolonesCPF; ERF; NOF; OFX
HWWTPI:CPF=2,468.70; ERF=nd; NOF=38.11; OFX=20.27; PEF=nd
HWWTPE:CPF=38.06; ERF=nd; NOF=25.69; OFX=nd; PEF=nd
RW:CPF, ERF, NOF, OFX=nd
SPE-UHPLC-FL-(QqQ)MS/MS
na CPF, ERF, NOF, OFX=12.5-125
Finland(Vieno, Härkki, et al. 2007)
RW (Vantaa River) Quinolones:FluoroquinolonesCPF; NOF; OFX
Min-max RW:CPF=<LOQ; NOF=<LOQ; OFX=<LOQ-5
SPE-LC-(QqQ)MS/MS
na CPF=24; NOF=24; OFX=2.6
(Vieno, Tuhkanen, et al. 2007)
WWTPI; WWTPE (Aura; Helsinki; Hyvinkää, Joensuu; Jyväskylä; Lappeenranta; Nurmijärvi; Oulu; Riihimäki; Tampere; Turku; Vaasa)
Quinolones:FluoroquinolonesCPF; NOF; OFX
Min-max WWTPI:CPF=nd-4,230; NOF=nd-960; OFX=nd-350
WWTPE:CPF=nd-130; NOF=nd-110; OFX=nd-30
SPE-LC-(QqQ)MS/MS
na CPF=29-163; NOF=24-78; OFX=5.8-18
(Vieno et al. 2006)
WWTPI; WWTPE (Riihimäki; Hyvinkää, Kalteva; Nurmijärvi, Klaukkala); RW (Vantaa and Luhtajoki Rivers)
Quinolones:FluoroquinolonesCPF; NOF; OFX
Min-max WWTPI:PF=200-450; NOF=<LOQ-180;OFX=30-130
WWTPE:CPF=<LOQ-40; NOF=<LOQ-40; OFX=<LOQ-10
RW:CPF=<LOQ-25; NOF =<LOQ; OFX=<LOQ
SPE-LC-(QqQ)MS/MS
na CPF=24-163; NOF=24-78; OFX=2.6-18
France(Jeanton et al. 2014)
RW (Allier River) Tetracycline:DXC
Min-max RW:DOX=nd-1.8
SPE-RRLC-(QqQ)MS/MS
na DOX=1
(Pasquini et al. 2014)
WWTPI; WWTPE (Nancy)
Macrolide: ERT
Mean WWTPI:ERT=150-200
WWTPE:ERT=100-200
SPE-LC-MS/MS ERT=50 ERT=100
Quinolone:FluoroquinoloneOFX
OFX=300-600 OFX=100-500 OFX=50 OFX=100
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
(Dévier et al. 2013)
DW (bottled natural mineral water, EVIAN and VOLVIC factories)
Amphenicols:CRP; TAP
DW:CRP, TAP=nd
SPME-RRLC-(QqQ)MS/MS
CRP=5; TAP=5 CRP=5; TAP=10
β-lactams: Cephalosporins CLX; CPD; CRX; CTF; CTXPenicillins AMP; AMX; CXC; DCX; OXC; PNG; PNV
CLX, CPD, CRX, CTF, CTX, AMP, AMX, CXC, DCX, OXC, PNG, PNV=nd
CLX=8; CPD=2; CRX=2; CTF=3; CTX=3; AMP=3; AMX=10; CXC=0.4; DCX=0.7; OXC=0.4; PNG=0.5; PNV=0.5
CLX=10; CPD=100; CRX=10; CTF=100; CTX=10; AMP=10; AMX=80; CXC=10; DCX=10; OXC=10; PNG=10; PNV=10
Diaminopyrimidine:TMT
TMT=nd TMT=0.7 TMT=1
Lincosamides:CDM; LCM
CDM, LCM=nd CDM=0.2; LCM=3 CDM=5; LCM=5
Macrolides:AZT; CTR; ERT; JSM; RXT; SPR; TLS
AZT, CTR, ERT, JSM, RXT, SPR, TLS=nd AZT=11; CTR=0.4; ERT=3; JSM=2; RXT=1; SPR=13; TLS=3
AZT, CTR, ERT, JSM, RXT, SPR, TLS=5
Nitroimidazole:MND
MND=nd MND=0.4 MND=2
Quinolones:FluoroquinolonesCPF; ERF; MBF; NOF; OFXOther quinolonesFMQ; OXA; PPA
CPF, ERF, MBF, NOF, OFX, FMQ, OXA, PPA=nd CPF=3; ERF=2; MBF=1; NOF=2; OFX=0.8; FMQ=0.1; OXA=0.1; PPA=2
CPF=5; ERF=5; MBF=5; NOF=5; OFX=2; FMQ=2; OXA=5; PPA=5
Steroid antibacterial:FSA
FSA=nd FSA=10 FSA=15
Streptogramin:VGN
VGN=nd VGN=4 VGN=10
Sulfonamides:SDM; SDZ; SMR; SMT; SMX; SMZ; SNL; SPD; STA
SDM, SDZ, SMR, SMT, SMX, SMZ, SNL, SPD, STA=nd SDM=0.1; SDZ=0.4; SMR=0.5; SMT=0.4; SMX=1; SMZ=0.2; SNL=37; SPD=0.5; STA=0.4
SDM=1; SDZ=15; SMR=1; SMT=1; SMX=1; SMZ=1; SNL=150; SPD=1; STA=1
Tetracyclines:CTC; DXC; OXT; TTC
CTC, DXC, OXT, TTC=nd CTC=2; DXC=0.9; OXT=1; TTC=0.7
CTC=5; DXC=3; OXT=2; TTC=5
Others: MNN; SLN
MNN, SLN=nd MNN=27; SLN=70 MNN=2; SLN=1,400
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
(Dinh et al. 2011)
RW (Seine, Charmoise, and Prédecelle Rivers)
β-lactams: CephalosporinCTXPenicillin AMX
Min-max RW:CTX=<LOQ; AMX=<LOQ-68
SPE-LC-(QqQ)MS/MS
CTX=13.7; AMX=12.0
CTX=45.6; AMX=39.2
Diaminopyrimidine:OMT; TMT
OMT=<LOQ; TMT=<LOQ-254 OMT=1.9; TMT=1.5
OMT=6.2; TMT=4.8
Glycopeptide:VCM
VCM=<LOQ-90 VCM=2.0 VCM=6.7
Macrolides:ERT; TLS
ERT=<LOQ-131; TLS =<LOQ 2.8 ERT=0.8; TLS=0.6 ERT=2.5; TLS=1.9
Nitroimidazole:OND
OND=<LOQ OND=4.3 OND=14.1
Quinolones:FluoroquinolonesCPF; ENX; ERF; LMF; NOF; OFX; SRFOther quinolonesFMQ; NLA; OXA; PPA
CPF=<LOQ-135; ENX=<LOQ; ERF=<LOQ; LMF=<LOQ; NOF=<LOQ-75; OFX=2.3-231; SRF=<LOQ; FMQ=<LOQ-4.6; NLA=<LOQ; OXA=<LOQ-23; PPA=<LOQ
CPF=1.0; ENX=2.2; ERF=3.3; LMF=3.3; NOF=2.1; OFX =0.5; SRF=1.1; FMQ=1.1; NLA=1.3; OXA=1.7; PPA=5.0
CPF=3.3; ENX=8.7; ERF=11.0; LMF=11.0; NOF=7.0; OFX=1.7; SRF=3.6; FMQ=3.5; NLA=4.3; OXA=5.7; PPA=16.5
Sulfonamides:SMX; SMZ
SMX=3.6-1,435; SMZ=<LOQ SMX=0.6; SMZ=1.4
SMX=2.0; SMZ=4.7
Tetracyclines:CTC; TTC
CTC=<LOQ; TTC=<LOQ-7.4 CTC=2.3; TTC=1.8 CTC=7.7; TTC=6.0
(Felizzola and Chiron 2009)
RW (Arc River) Macrolides: AZT; CTR
Max RW:AZT=nd; CTR =nd-2,330
SPE-LC-MS/MS na AZT, CTR=4-150
Quinolone:FluoroquinoloneCPF
CPF =nd-9,660 na CPF=4-150
Sulfonamide:SMX
SMX=nd na SMX=4-150
Tetracycline:OTC
OXT=nd na OXT=4-150
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
(Tamtam et al. 2008)
RW (Seine, Marne, and Oise Rivers)
Diaminopyrimidine:TMT
Max RW:TMT=16-45
SPE-UPLC-(QqQ)MS/MS
na TMT=10
Nitroimidazole:OND
OND=<LOQ-58 na OND=10
Quinolones:FluoroquinolonesCPF; DIF; DNF; ENX; ERF; LMF; NOF; OFX; SRF Other quinolonesFMQ
CPF=<LOQ; DIF=<LOQ; DNF=<LOQ-19; ENX=<LOQ-11; ERF=<LOQ-10; LMF=<LOQ-10; NOF=13-163; OFX=<LOQ-55; SRF=<LOQ-10; FMQ=13
na CPF, DIF, DNF, ENX, ERF, LMF, NOF, OFX, SRF, FMQ=10
Sulfonamides: SMX; SMZ
SMX=72-544; SMZ=<LOQ na SMX, SMZ=10
(Andreozzi et al. 2003)
WWTPE (Lyon) Diaminopyrimidine:TMT
Min-max WWTPE:TMT=20-40
SPE-HPLC-MS/MS na na
Quinolones:FluoroquinolonesCPF; ENX; LMF; NOF; OFX
CPF=60; ENX=10-30; LMF=180-190; NOF=50-80; OFX=330-510 na na
Sulfonamide:SMX
SMX=70-90 na na
Germany(Baumann et al. 2015)
WWTPE; RW (Bavaria)
Macrolide:CTR
Min-max WWTPE:CTR=110-460
RW:CTR=4-100
SPE-LC-(QqQ-IT)MS/MS
na CTR=2
(Maier et al. 2015)
WWTPE (Langwiese); RW (Schussen andArgen Rivers)
Sulfonamide: SMX
Min-max WWTPE:SMX=380-510
RW:SMX=17-64
SPE-LC-MS/MS na SMX=10
(Rossmann et al. 2014)
WWTPI; WWTPE (Dresden; Kaditz)
β-lactams: Cephalosporins CRX; CTXPenicillinsAMX; PNV; PPR
Min-max WWTPI:CRX=49-6,196; CTX=nd-492; AMX=nd-1,270; PNV=nd-252; PPR=nd-2,603
WWTPE:CRX=nd-1,957; CTX=nd-217; AMX=nd-187; PNV=nd; PPR=nd-1,205
SPE-LC-(QqQ)MS/MS
CRX=29.7; CTX=10.6; AMX=2.8; PNV=2.3; PPR=3.0
CRX=99.0; CTX=35.2; AMX=9.3; PNV=7.7; PPR=9.9
Diaminopyrimidine:TMT
TMT=22-372 TMT=25-554 TMT=3.1 TMT=10.2
Glycopeptide:VCM
VCM=nd-664 VCM=nd-348 CDM=0.4 CDM=1.4
Lincosamide:CDM
CDM=11-163 CDM=20-882 VCM=75.3 VCM=245.1
Macrolides:AZT; CTR; RXT
AZT=50-946; CTR=42-1,525; RXT=nd-771
AZT=nd-956; CTR=18-1,800; RXT=nd-181
AZT=0.2; CTR=0.5; RXT=1.1
AZT=0.8; CTR=1.6; RXT=3.8
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Quinolones:FluoroquinolonesCPF; LVF
CPF=78-1,570; LVF=25-2,247 CPF=19-920; LVF=28-836 CPF=2.2; LVF=1.4 CPF=7.3; LVF=4.8
Sulfonamide:SMX
SMX=12-2,204 SMX=18-8,263 SMX=5.1 SMX=17.1
Tetracycline:DXC
DXC=nd-2,393 DXC=nd-1,110 DXC=8.8 DXC=29.2
(Nödler et al. 2010)
WWTPE; RW (Leine River, Göttingen); SeaW (Baltic Sea, Ahlbeck)
Diaminopyrimidine:TMT
WWTPE:TMT=681
RW:TMT=95
SeaW:TMT=nd
SPE-HPLC-(QqQ)MS/MS
na TMT=2.5-15
Macrolides:CTR; ERT; RXT
CTR=520; ERT=173; RXT=509
CTR=77; ERT=22; RXT=16
CTR=14; ERT=nd; RXT=nd
CTR=7.5-18; ERT=7.5-29; RXT=9.5-115
Sulfonamide:SMX
SMX=509 SMX=93 SMX=7 SMX=2.6-14
(Christian et al. 2003)
RW (Southern North Rhine-Westphalia, Greater Cologne-Bonn;Eastern Westphalia; region Lower-Rhine; region Rhine-Sieg)
β-lactams: Penicillin AMP; AMX; BZP; CXC; DCX; FCX; MTC; MZC; OXC; PNX; PPR
Min-max RW:AMP=nd; AMX=nd-6; BZP=nd; CXC=nd; DCX=nd; FCX=nd-7; MTC=nd; MZC=nd; OXC=nd; PNX=nd; PPR=nd-48
SPE-HPLC-MS/MS na AMP, AMX, BZP, CXC, DCX, FCX, MTC, MZC, OXC, PNX, PPR=5
Diaminopyrimidine:TMT
TMT=nd-50 na TMT=2
Lincosamide:CDM
CDM=nd-32 na CDM=1
Macrolides:AZT; CTR; ERT; RXT; SPR; TLS
AZT=nd-15; CTR=nd-37; ERT=nd-302; RXT=nd-31; SPR=nd; TLS=nd
na AZT=1; CTR=0.5; ERT=2; RXT=2; SPR=2; TLS=2
Quinolones:FluoroquinolonesCPF; OFX
CPF=nd-9; OFX=nd-20 na CPF=5; OFX=2
Sulfonamides:SDD; SMX
SDD=nd-7; SMX=nd-300 na SDD, SMX=2
Tetracyclines:CTC; DXC; OXT; TTC
CTC, DXC, OXT, TTC=nd na CTC, DXC, OXT, TTC=10
Greece(Alygizakis et al. 2016)
SeaW (Aegean Sea, Saronikos Gulf andElefsis Bay)
Amphenicols:CRP; FFN; TAP
Min-max SeaW:CRP, FFN, TAP=nd
SPE-LC-(QqQ)MS/MS
CRP=2.4; FFN=0.3; TAP=0.01
CRP=7.2; FFN=0.9; TAP=0.03
β-lactams: CephalosporinCLXPenicillinAMX
CLX=nd; AMX=nd-127.8 CLX, AMX=5.0 CLX, AMX=15.0
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Diaminopyrimidine:TMT
TMT=nd-3.4 TMT=0.4 TMT=1.2
Lincosamide:LCM LCM=nd
LCM=0.07 LCM=0.2
Macrolides:AZT; CTR; ERT; TLS
AZT=nd; CTR=nd-<LOQ; ERT=nd; TLS=nd-2.4 AZT=0.1; CTR=1.0; ERT=5.0; TLS=0.7
AZT=0.3; CTR=3.0; ERT=1.7; TLS=2.2
Nitroimidazole:MND
MND=nd-8.2 MND=1.3 MND=3.8
Pleuromutilin:TAM
TAM=nd-<LOQ TAM=0.1 TAM=0.3
Quinolones:FluoroquinolonesCPF; DIF; ERF; MBF; NOF; OFX; SRFOther quinolonesFMQ; OXA
CPF=nd; DIF=nd; ERF=nd; MBF=nd; NOF=nd; OFX=nd-<LOQ; SRF=nd; FMQ=nd; OXA=nd-<LOQ
CPF=2.3; DIF=1.8; ERF=1.7; MBF=0.2; NOF=6.1; OFX=1.6; SRF=2.8; FMQ=1.0; OXA=1.3
CPF=6.9; DIF=5.4; ERF=5.1; MBF=0.6; NOF=18.3; OFX=4.7; SRF=4.8; FMQ=3.0; OXA=3.8
Sulfonamides:SCP; SCZ; SDD; SDM; SDX; SDZ; SGD; SMM; SMP; SMR; SMT; SMX; SPD; SQN; SSX; SXL
SCP=nd; SCZ=nd; SDD=nd; SDM=nd; SDX=nd; SDZ=nd-2.2; SGD=nd; SMM=nd; SMP=nd; SMR=nd; SMT=nd; SMX=nd-6.3; SPD=nd; SQN=nd; SSX=nd; STA=nd-<LOQ; SXL=nd
SCP=2.2; SCZ=2.2; SDD=0.02; SDM=0.8; SDX=1.1; SDZ=0.1; SGD=8.3; SMM=0.3; SMP=0.3; SMR=0.2; SMT=1.0; SMX=0.1; SPD=0.2; SQN=1.6; SSX=3.1; STA=0.6; SXL=0.6
SCP=6.6; SCZ=6.6; SDD=0.06; SDM=2.4; SDX=3.3; SDZ=0.3; SGD=24.9; SMM=0.9; SMP=0.9; SMR=0.6; SMT=3.0; SMX=0.3; SPD=0.6; SQN=4.8; SSX=9.3; STA=1.8; SXL=1.8
Tetracyclines:CTC; DXC; OXT; TTC
CTC, DXC, OXT, TTC=nd CTC=4.3; DXC=20.6; OXT=4.6; TTC=11.8
CTC=12.9; DXC=61.8; OXT=13.8; TTC=35.4
(Papageorgiou et al. 2016)
WWTPI; WWTPE (Volos)
β-lactams: PenicillinsAMP; AMX
Min-max WWTPI:AMP=nd-1,805; AMX=nd
WWTPE:AMP=nd-498; AMX=nd
SPE-LC-DAD-(QqQ)MS/MS
AMP=24.7-81.5; AMX=161.2-553.2
AMP=21.3-70.3; AMX=156.3-515.8
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Diaminopyrimidine:TMT
TMT=<LOQ-200 TMT=nd-95.8 TMT=3.5-11.7 TMT=2.4-7.8
Lincosamide:LCM
LCM=nd-281 LCM=nd-<LOQ LCM=16.2-53.5 LCM=14.3-47.7
Macrolides:ERT; RXT
ERT=nd-320; RXT=nd-<LOQ ERT, RXT=nd ERT=32.8-108.2; RXT=26.3-86.8
ERT=24.3-80.2; RXT=24.4-80.6
Nitroimidazole:MND
MND=nd-64.7 MND=nd-35.2 MND=7.5-24.7 MND=5-16.5
Quinolones:FluoroquinolonesCPF; MXF
CPF=nd-591; MXF=nd-773 CPF=nd-591; MXF=nd-298 CPF=18.4-60.7; MXF=18.8-62.1
CPF=14.7-48.6; MXF=14.5-47.8
Sulfonamides:SDZ; SMX
SDZ=nd-846; SMX=nd-507 SDZ=nd-194; SMX=nd-80 SDZ=27.6-91; SMX=4.7-15.6
SDZ=18.4-607; SMX=3.2-10.4
(Kosma et al. 2014)
WWTPI; WWTPE (Ioannina; Arta; Preveza; Agrinio; Grevena; Kozani; Veroia)
Diaminopyrimidine:TMT
Min-max WWTPI:TMT=nd-1,866.2
WWTPE:TMT=nd-533.2
SPE-LC-UV/Vis-(Q-LIT-ORBITRAP)MS/MS
TMT=2.1-3.4 TMT=6.2-10.9
Sulfonamide:SMX
SMX=nd-2,626.3 SMX=nd-481.3 SMX=3.5-4.0 SMX=10.5-12.4
(Andreozzi et al. 2003)
WWTPE (Iraklio) Diaminopyrimidine:TMT
Min-max WWTPE:TMT=40
SPE-HPLC-MS/MS na na
Quinolones:FluoroquinolonesCPF; ENX; LMF; NOF; OFX
CPF=70; ENX=30; LMF=290; NOF=70; OFX=460 na na
Sulfonamide:SMX
SMX=10 na na
Ireland(McEneff et al. 2014)
WWTPE (east and west coast); SW (marine)
Diaminopyrimidine:TMT
Min-max WWTPE:TMT=60-1,200
SW:TMT=70-870
SPE-LC-(IT)MS/MS
na TMT=3-49
Italy(Celano et al. 2014)
WWTPI; WWTPE; DW; SeaW
Sulfonamide:SMX
WWTPI:SMX=104.5
WWTPE:SMX=53.4
DW:SMX=<LOQ
SeaW:SMX=nd
SPE-DLLME-UHPLC-(QqQ)MS/MS
SMX=3.8-15.1 SMX=12.5-49.9
(Verlicchi et al. 2014)
WWTPI; WWTPE; SW (Po Valley)
Diaminopyrimidine:TMT
Mean WWTPI:TMT=59
WWTPE:TMT=40
SW:TMT=2
SPE-HPLC-(QqQ-LIT)MS/MS
TMT=1 na
Macrolides:AZT; CTR; ERT; RXT
AZT=120; CTR=200; ERT=46; RXT=65
AZT=130; CTR=280; ERT=15; RXT=290
AZT=7; CTR=6; ERT=nd; RXT=nd
AZT=1-4; CTR=1-6; ERT=4-8; RXT=1-3
na
Nitroimidazole:MND
MND=42 MND=28 MND=nd MND=1-4 na
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Quinolones:FluoroquinolonesCPF; NOF; OFX
CPF=2,200; NOF=210; OFX=980
CPF=630; NOF=150; OFX=400
CPF=25; NOF=nd; OFX=nd
CPF=1-3; NOF=1-6; OFX=1
na
Tetracyclines:DXC; TTC
DXC, TTC=nd DXC, TTC=nd DXC, TTC=nd DXC=2-18; TTC=5-14
na
(Al Aukidy et al. 2012)
WWTPE; RW (Po Valley)
Diaminopyrimidine:TMT
Mean WWTPE:TMT=nd-27
RW:TMT=1-15
SPE-HPLC–(QqQ-LIT)MS/MS
TMT=0.5 TMT=2-7
Macrolides:AZT; CTR; RXT
AZT=44-175; CTR=102-283; RXT=nd
AZT=4-90; CTR=1-100; RXT=nd
AZT=1; CTR=0.5; RXT=0.5
AZT=3-17; CTR=2-13; RXT=2-7
Nitroimidazole:MND
MND=16-19 MND=nd-10.5 MND=0.5 MND=1-7
Quinolone:FluoroquinoloneCPF
CPF=25-284 CPF=nd-100 CPF=1 CPF=3-7
Sulfonamide:SMX
SMX=91-97 SMX=3.5-4.5 SMX=1 SMX=3-7
(Verlicchi et al. 2012)
WWTPI; WWTPE; HWWTPE
Amphenicol:CRP
Min-max WWTPI:CRP=13-24
WWTPE:CRP=nd
HWWTPE:CRP=nd-36
SPE-HPLC–(QqQ-LIT)MS/MS
CRP=4-9 na
Diaminopyrimidine:TMT
TMT=39-72 TMT=36-51 TMT=68-1,800 TMT=1-2 na
Macrolides:AZT; CTR; ERT; JSM; RXT; SPR; TLS; TMC
AZT=10-330; CTR=110-780; ERT=26573; JSM=nd-7; RXT=nd-140; SPR;=nd-150; TLS=nd; TMC=21-460
AZT=70-180; CTR=260-310, ERT=12328; JSM=nd; RXT=13-53; SPR=19-53; TLS=nd; TMC=nd-81
AZT=nd-1,040; CTR=20-14,000; ERT=60-320; JSM=nd-15; RXT=nd-140; SPR=nd-110; TLS=nd; TMC=14-350
AZT=2-4; CTR=2-6; ERT=5-8; JSM=1-3; RXT=2-6; SPR=2-3; TLS=1-3; TMC=1-6
na
Nitroimidazole:MND
MND=28-56 MND=13-41 MND=260-1,640 MND=1-6 na
Quinolones:FluoroquinolonesCPF; DNF; ENX; ERF; NOF; OFX
CPF=1,100-3,700; DNF=nd; ENX=81-130; ERF=nd; NOF=150-310; OFX=450-2,200
CPF=290-1,100;DNF=nd; ENX=30-100; ERF=nd; NOF=140-170; OFX=220-520
CPF=1,400-26,000; DNF=nd; ENX=58-480; ERF=nd; NOF=23-510; OFX=3,300-37,000
CPF=2-4; DNF=3-9; ENX=2-7; ERF=2-5; NOF=3-8; OFX=1-2
na
Sulfonamides:SDZ; SMZ; SMX
SDZ=13-26; SMZ=10-33; SMX=280-740
SDZ=10-21; SMZ=10-15; SMX=170-240
SDZ=29-380; SMZ=nd-30; SMX=900-6,500
SDZ=2-7; SMX=1-3; SMZ=2-6
na
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Tetracyclines:CTC; DXC; OXT; TTC
CTC, DXC, OXT, TTC=nd
CTC, DXC, OXT, TTC=nd
CTC=nd-94; DXC=nd-70; OXT=nd-1,300; TTC=nd-33
CTC=8-14; DXC=8-18; OXT=6-15; TTC=7-14
na
(Zuccato et al. 2010)
WWTPI; WWTPE (Varese); RW (Po and Arno Rivers)
β-lactam:PenicillinAMX
WWTPI:AMX=18
WWTPE:AMX=<LOQ
RW:AMX=<LOQ-9.91
SPE-HPLC-(QqQ)MS/MS
na AMX=2.08
Glycopeptide:VCM
VCM=41 VCM=29 VCM=0.44-11.69 na VCM=na
Lincosamide:LCM
LCM=9.7 LCM=7.2 LCM=3.72-10.92 na LCM=0.31
Macrolides:CTR; ERT; OLD; SPR; TLS; TMC
CTR=319; ERT=12; OLD=2.2; SPR=603; TLS=<LOQ; TMC=<LOQ
CTR=145; ERT=72; OLD=3.1; SPR=375; TLS=<LOQ; TMC=<LOQ
CTR=0.89-44.76; ERT=0.78-8.12; OLD=<LOQ; SPR=<LOQ 2.35-17.92; TLS=<LOQ; TMC=<LOQ -6.67
na CTR=0.15; ERT=0.4; OLD=0.31; SPR=1.4; TLS=0.77; TMC=0.71
Quinolone:FluoroquinoloneCPF
CPF=513 CPF=148 CPF=1.32-37.50 na CPF=1.8
Sulfonamide:SMX
SMX=246 SMX=101 SMX=1.79-11.40 na SMX=1.48
Tetracycline:OXT
OXT=<LOQ OXT=<LOQ OXT=1.23-1.82 na OXT=1.19
(Castiglioni et al. 2005)
WWTPE (Cagliari; Cosenza; Palermo; Latina; Naples; Cuneo; Varese Olona; Varese Lago)
β-lactam: PenicillinAMX
Min-max WWTPE:AMX=nd-120
SPE-HPLC-(QqQ)MS/MS
na AMX=2.08
Lincosamide:LCM
LCM=11-846 na LCM=0.31
Macrolides:CTR; ERT; OLD; SPR; TLS; TMC
CTR=8-73; ERT=9-353; OLD=nd; SPR=1.4-161; TLS=nd-0.9; TMC=nd
na CTR=0.15; ERT=0.4; OLD=0.31; SPR=1.4; TLS=0.77; TMC=0.71
Quinolones:FluoroquinolonesCPF; OFX
CPF=27-378; OFX=150-1,081 na CPF=1.8; OFX=1.3
Sulfonamide:SMX
SMX=46-317 na SMX=1.48
Tetracycline:OXT
OXT=nd na OXT=1.19
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
(Zuccato et al. 2005)
WWTPE (Cagliari; Latina; Cuneo; Varese; Cosenza; Palermo; Naples; Monza); RW (Po and Lambro Rivers)
β-lactam: PenicillinAMX
Median WWTPE:AMX=47.0
RW:AMX=nd
SPE-HPLC-(QqQ)MS/MS
na na
Lincosamide:LCM
LCM=30.5 LCM=24.4-32.6 na na
Macrolides:CTR; ERT; SPR
CTR=18.1; ERT=47.4; SPR=75.0 CTR=1.6-8.3; ERT=3.2-4.5; SPR=9.8-72.0
na na
Quinolones:FluoroquinolonesCPF; OFX
CPF=251.0; OFX=600.0 CPF=n-14.4; OFX=33.1-306.1 na na
Sulfonamide:SMX
SMX=127.2 SMX=nd na na
(Andreozzi et al. 2004)
WWTPE (Cagliari; Cosenza; Palermo; Roma; Napoli; Torino; Varese; Olona; Varese Lago)
β-lactam: PenicillinAMX
Min-max WWTPE:AMX=4.68-120.35
SPE-HPLC-(QqQ)MS/MS
na AMX=1.8
(Andreozzi et al. 2003)
WWTPE (Latina; Rome; Naples)
Diaminopyrimidine:TMT
Min-max WWTPE:TMT=30-130
SPE-HPLC-MS/MS na na
Quinolones:FluoroquinolonesCPF; ENX; LMF; NOF; OFX
CPF=40-70; ENX=10-30; LMF=180-320; NOF=60-70; OFX=290-580 na na
Sulfonamide:SMX
SMX=nd-30 na na
Luxembourg(Pailler et al. 2009)
WWTPI; WWTPE (Beggen); RW (Alzette and Mess Rivers)
Sulfonamides:SDM; SMX; SMZ; STA
Min-max WWTPI:SDM=<LOQ-26; SMX=1-155; SMZ=<LOQ-2; STA=<LOQ-2
WWTPE:SDM=<LOQ-9; SMX=4-39; SMZ=<LOQ; STA=<LOQ
RW:SDM=<LOQ-3; SMX=<LOQ-22; SMZ=<LOQ; STA=<LOQ-2
SPE-LC-(QqQ)MS/MS
SDM, SMX, SMZ, STA=0.3
SDM, SMX, SMZ, STA=1.0
Tetracyclines:TTC; OXT
TTC=<LOQ-85; OXT=<LOQ-7
TTC=<LOQ-24; OXT=<LOQ-5
TTC=<LOQ-8; OXT=<LOQ-7
TTC, OXT=0.3 TTC, OXT=1.0
Netherlands(Chitescu et al. 2012)
SW; GW β-lactam: PenicillinDCX
Max SW:DCX=nd
GW:DCX=nd
SPE-UPLC-(QqQ-ORBITRAP)MS/MS
DCX=100 na
Macrolide:ERT
ERT=75-100 ERT=nd ERT=50 na
Quinolone:FluoroquinoloneCPF
CPF=nd CPF=nd CPF=100 na
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Sulfonamide:SMX
SMX=75-100 SMX=50-75 SMX=10 na
Tetracyclines:OXT
OXT=nd OXT=nd OXT=50 na
(Jongh et al. 2012)
SW (Rhine, Meuse, Haringvliet, and Drentsche Aa Rivers); DW
Macrolide:CTR; ERT
Max SW:CTR=16; ERT=35
DW:CTR, ERT=nd
SPE-LC-(QLT-FT-ORBITRAP)MS/MS
CTR, ERT=10 na
(Laak et al. 2010)
RW (Rhine River) Diaminopyrimidine:TMT
Min-max RW:TMT=5-10
SPE-HPLC-(QqQ)MS/MS
TMT=5 na
Lincosamide:CDM
CDM=12-23 CDM=10 na
Macrolides:CTR; ERT; RXT
CTR=10-18; ERT=17-40; RXT=10-18 CTR=10; ERT=10; RXT=10
na
Sulfonamide:SMX
SMX=20-40 SMX=10 na
Poland(Sikorska et al. 2015)
WW; TW (food-producing animal farm)
Aminoglycosides: StreptomycinsDST; STMOther aminoglycoside NMC
Min-max WW; TW:DST=nd; STM=nd; NMC=nd-32,000
SPE-LC-(QqQ)MS/MS
DST=730; STM=360; NMC=3,790
DST=2,000; STM=1,000; NMC=10,000
β-lactams: Cephalosporins CLX; CPR; CPZ; CQN; CTF; CZL Penicillins AMP; AMX; DCX; NFC; OXC; PNG
CLX, CPR, CPZ, CQN, CTF, CZL, AMP, AMX, DCX, NFC, OXC, PNG=nd
CLX=10; CPR=10; CPR=20; CQN=10; CTF=20; CZL=10; AMP=20; AMX=3,540; DCX=20; NFC=20; OXC=20; PNG=3,720
CLX=20; CPR=20; CPR=50; CQN=20; CTF=50; CZL=20; AMP=50; AMX=10,000; DCX=50; NFC=50; OXC=50; PNG=10,000
Diaminopyrimidine:TMT
TMT=nd-17,800 TMT=20 TMT=50
Lincosamide:LCM
LCM=nd-304,000 LCM=10 LCM=20
Macrolides:ERT; JSM; SPR; TLS; TMC
ERT=nd; JSM=nd; SPR=nd; TLS=nd; TMC=nd-1,730 ERT=2,030; JSM=20; SPR=20; TLS=10; TMC=10
ERT=5,000; JSM=50; SPR=50; TLS=20; TMC=20
Pleuromutilin:TAM
TAM=nd-66,800 TAM=10 TAM=20
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Quinolones:FluoroquinolonesCPF; DIF; DNF; ERF; MBF; NOF; SRF Other quinolonesFMQ; NLA; OXA
CPF=nd; DIF=nd; DNF=nd; ERF=nd-1,670; MBF=nd; NOF=nd-3,48; SRF=nd; FMQ=nd; NLA=nd; OXA=nd
CPF, DIF, DNF, ERF, MBF, NOF, SRF, FMQ, NLA, OXA=10
CPF, DIF, DNF, ERF, MBF, NOF, SRF, FMQ, NLA, OXA=20
Sulfonamides:SDM; SMM; SMR; SMX; SMZ; STA
SDM=nd; SMM=nd; SMR=nd; SMX=nd-58,700; SMZ=nd; STA=nd SDM=10; SMM=10; SMR=10; SMX=10; SMZ=10; STA=20
SDM=20; SMM=20; SMR=20; SMX=20; SMZ=20; STA=50
Tetracyclines:CTC; DXC; OXT; TTC
CTC=nd; DXC=nd-1,650; OXT=nd; TTC=nd CTC=20; DXC=20; OXT=10; TTC=20
CTC=50; DXC=50; OXT=20; TTC=50
Others: SPT
SPT=nd SPT=350 SPT=1,000
(Wagil et al. 2015)
RW (Gościcina River)
Nitroimidazole:MND
Min-max RW:MND=nd-136.2
SPE-LC-MS/MS MND=3.4 MND=10.1
(Wagil et al. 2014)
RW (Gościcina and Reda Rivers)
Quinolones:FluoroquinolonesCPF; ERF; NOF
Min-max RW:CPF=nd-2,745; ERF=nd-248.7; NOF=nd-442.8
SPE-UPLC-(QqQ)MS/MS
CPF=3.3; ERF=3.3; NOF=3.4
CPF=10.1; ERF=10.1, NOF=10.2
(Borecka et al. 2013)
SeaW (Baltic Sea) Diaminopyrimidine:TMT
Mean SeaW:TMT=nd-3.4
SPE-LC-(UIT)MS/MS
TMT=0.2 TMT=0.5
Macrolide:ERT
ERT=nd-<LOQ ERT=16.7 ERT=50.0
Sulfonamides:SCP; SDM; SMR; SMX; SMZ; SPD; SSX; STA; STZ
SCP=nd; SDM=nd-0.8; SMR=nd; SMX=nd-10.8; SMZ=nd-<LOQ; SPD=nd-<LOQ; SSX=nd; STA=nd-<LOQ
SCP=3.3; SDM=0.2; SMR=16.7; SMX=3.3; SMZ=1.7; SPD=1.7; SSX=3.3; STA=3.3; STZ=3.3
SCP=10.0; SDM=0.5; SMR=50.0; SMX=10.0; SMZ=5.0; SPD=5.0; SSX=10.0; STA=10.0; STZ=10.0
Portugal(Gaffney et al. 2015)
RW (Tagus and Zêzere Rivers); GW (OTA, Alenquer and Lezírias wells); DW
Macrolide:ERT
Max RW:ERT=4-31
GW:ERT=4
DW:ERT=5
SPE-UPLC-(QqQ)MS/MS
na na
Sulfonamides:SDZ; SMX; SMZ; SPD
SDZ=3-26; SMX=2-22; SMZ=1; SPD=2
SDZ=2M SMX=2; SMZ=1; SPD=7
SDZ=1; SMX=1.3; SMZ=0.5; SPD=1.9
na na
(Pereira et al. 2015)
WWTPI; WWTPE Macrolide:AZT
Min-max WWTPI:AZT=nd-719.3
WWTPE:AZT=nd
SPE-LC-MS/MS AZT=0.4-0.5 AZT=1.4-1.7
Quinolone:FluoroquinoloneCPF
CPF=nd-17,500.0 CPF=nd-9,8000.0 CPF=5.0-6.0 CPF=16.4-20.0
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
(Santos et al. 2013)
WWTPI; WWTPE; HWWTPE (Coimbra)
Diaminopyrimidine:TMT
Min-max WWTPI:TMT=nd-360
WWTPE:TMT=66.6-299
HWWTPE:TMT=nd-3,963
SPE-LC-(QqQ-LIT)MS/MS
TMT=0.8-1.4 TMT=2.5-4.6
Macrolides:AZT; CTR; ERT
AZT=79.7-295; CTR=nd-52.3; ERT=9.64-220
AZT=93.7-297; CTR=12.0-40.0; ERT=20.4-134
AZT=<LOQ-7,351; CTR=nd-960; ERT=nd-7,545
AZT=0.9-7.4; CTR=0.2-1.3; ERT=1.0-4.8
AZT=3.1-25.0; CTR=0.6-4.4; ERT=3.3-16.0
Nitroimidazole:MND
MND=<LOQ-113 MND=19.4-83.5 MND=nd-12,315 MND=1.0-12.0 MND=3.5-39.0
Quinolones:FluoroquinolonesCPF; OFX
CPF=107-330; OFX=51.9-4,986
CPF=127-1,396; OFX=110-366
CPF=101-38,689; OFX=nd-24,811
CPF=6.8-11.0; OFX=0.3-7.5
CPF=23.0-38.0; OFX=1.1-25.0
Sulfonamide:SMX
SMX=529-1,662 SMX=340-1,679 SMX=nd-8,714 SMX=2.7-3.1 SMX=9.1-10.0
Tetracycline:TTC
TTC=<LOQ-32.3 TTC=<LOQ-22.8 TTC=nd-<LOQ TTC=2.8-15.0 TTC=9.2-49.0
(Madureira et al. 2009)
RW (Douro River) Diaminopyrimidine:TMT
Min-max RW:TMT=nd-13.0
SPE-LC-(IT)MS/MS
TMT=1.25 TMT=3.24
Sulfonamide:SMX
SMX=nd-53.3 SMX=4.40 SMX=6.60
(Pena et al. 2007)
RW (Mondego River) Quinolones:FluoroquinolonesCPF; ERF; OFX
Min-max RW:CPF=nd-119.2; ERF=nd-102.5; OFX=nd
SPE-HPLC-FL na CPF, ERF, OFX=25
Romania(Chitescu et al. 2015)
RW (Danube, Olt, Siret, and Argeș Rivers); LW (Borcea and Călărași)
Amphenicol:CRP
Min-max RW:CRP=nd-13
LW:CRP=nd
SPE-LC-(Q-ORBITRAP)MS/MS
CRP=7.3 CRP=22.3
β-lactam: PenicillinDXC
DXC=nd DXC=nd DXC=12.9 DXC=39.2
Diaminopyrimidine:TMT
TMT=nd-12 TMT=nd TMT=6.5 TMT=17.2
Lincosamide:LCM
LCM=nd LCM=nd LCM=17.5 LCM=56.8
Macrolides:ERT; TLS; TMC
ERT=nd; TLS=nd-39; TMC=nd ERT=nd; TLS=17; TMC=nd ERT=15.5; TLS=9.7; TMC=2.1
ERT=47.1; TLS=24.9; TMC=6.4
Pleuromutilins:TAM; VNM
TAM=nd-3-5.6; VNM=nd TAM, VNM=nd TAM=1.6; VNM=2.0
TAM=4.8; VNM=6.2
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Quinolones:FluoroquinolonesCPF; NOFOther quinoloneFMQ
CPF=nd-6; NOF=nd; FMQ=nd CPF, NOF, FMQ=nd CPF=12.6; NOF=20.6; FMQ=3.2
CPF=38.2; NOF=62.5; FMQ=9.7
Sulfonamides:SDD; SDM; SDZ; SMX; SQN
SDD=nd; SDM=nd; SDZ=nd; SMX=nd-30; SQN=nd
SDD, SDM, SDZ, SMX, SQN=nd
SDD=1.0; SDM=3.4; SDZ=2.3; SMX=1.0; SQN=3.4
SDD=3.2; SDM=10.3; SDZ=7.0; SMX=3.0; SQN=10.3
Tetracyclines:CTC; OXT
DXC, OXT=nd DXC, OXT=nd DXC=8.8; OXT=8.0
DXC=26.6; OXT=24.3
(Chițescu and Nicolau 2014)
RW (Prahova, Timis, Danube, Siret, Prut, and Jijia Rivers); LW (Huși town); DW (Galați town)
β-lactam: PenicillinDXC
Min-max RW:DXC=nd
LW:DXC=nd
DW:DXC=nd
SPE-UHPLC-(ORBITRAP)MS
DXC=100 na
Diaminopyrimidine:TMT
TMT=10-20 TMT=nd TMT=nd TMT=5 na
Macrolide:ERT
ERT=15-25 ERT=nd ERT=nd ERT=5 na
Quinolone:FluoroquinoloneCPF
CPF=nd CPF=nd CPF=nd CPF=5 na
Sulfonamides:SMX
SMX=10-30 SMX=nd SMX=nd SMX=5 na
Tetracyclines:OXT
OXT=nd OXT=nd OXT=nd OXT=50 na
(Opriş et al. 2013)
WWTPI; WWTPE β-lactam: CephalosporinCTN; CTZPenicillinAMP; AMX; PNG
Min-max WWTPI:CTN=nd-334,000; CTZ=nd; AMP=nd, AMX=nd, PNG=nd
WWTPE:CTN, CTZ, AMP, AMX, PNG=nd
SPE-LC-DAD-(Q)MS
CTN=920; CTZ=700; AMP=70; AMX=280; PNG=270
CTN=2,770; CTZ=2,140; AMP=210; AMX=850; PNG=810
Tetracyclines:DXC; TTC
DXC=nd-110,000; TTC=nd-146,000
SCX, TTC=nd DXC, TTC=900 DXC=2,720; TTC=2,720
Slovakia(Birošová et al. 2014)
WWTPI; WWTPE β-lactam: PenicillinPNV
Min-max WWTPI:PNV=<LOQ
WWTPE:PNV=<LOQ
SPE-LC-(Q-ORBITRP)MS
na PNV=0.05-50
Diaminopyrimidine:TMT
TMT=99-187 TMT=86-88 na TMT=0.05-50
Lincosamide:CDM
CDM=44-70 CDM=35-69 na CDM=0.05-50
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Macrolides:AZT; CTR; ERT; RXT
AZT=276-1,360; CTR=771-2,520; ERT=79-118; RXT=<LOQ 5.5
AZT=266-1,220; CTR=624-1,890; ERT=12-20; RXT=<LOQ
na AZT, CTR, ERT, RXT=0.05-50
Quinolones:FluoroquinolonesCPF; DIF; ENX; ERF; LMF; LVF; NOFOther quinoloneOXA
CPF=484-2,710; DIF=<LOQ; ENX=<LOQ-12-39; ERF=<LOQ-14; LMF=<LOQ; LVF=55-239; NOF=46-404; OXA=<LOQ
CPF=96-338; DIF=<LOQ; ENX=<LOQ-8; ERF=<LOQ-2.6; LMF=<LOQ; LVF=23-58; NOF=13-33; OXA=<LOQ
na CPF, DIF, ENX, ERF, LMF, LVF, NOF, OXA=0.05-50
Sulfonamides:SDM; ; SDZ; SMP; SMR; SMT; SMX; SMZ; SPD; SPN; SQN; SSL; STA; SXL; SXL
SDM=<LOQ; SDZ=<LOQ-18; SMP=<LOQ; SMR=<LOQ; SMT=28-57; SMX=51-320; SMZ=<LOQ; SPD=137-419; SPN=<LOQ; SQN=<LOQ-8.1; SSL=26-124; STA=<LOQ; SXL=<LOQ; SXL=<LOQ
SDM=<LOQ; SDZ=<LOQ; SMP=<LOQ; SMR=<LOQ; SMT=<LOQ; SMX=9.2-108; SMZ=<LOQ; SPD=15-120; SPN=<LOQ; SQN=<LOQ; SSL=7.5-124; STA=<LOQ; SXL=<LOQ; SXL=<LOQ
na SDM, , SDZ, SMP, SMR, SMT, SMX, SMZ, SPD, SPN, SQN, SSL, STA, SXL, SXL=0.05-50
Tetracyclines:DXC; OXT; TTC
DXC=12-48; OXT=<LOQ-9.1; TTC=<LOQ-22
DXC=<LOQ-7-8; OXT=<LOQ; TTC=<LOQ-3.1
na DXC, OXT, TTC=0.05-50
Spain(Boix et al. 2015)
WWTPE (Castellon; Valencia Provinces); SW
Diaminopyrimidine:TMT
Min-max WWTPE:TMT=nd-86
SW:TMT=nd-5
SPE-UHPLC-(QqQ-IT)MS/MS
TMT=1.8-2.3 na
Lincosamide:LCM
LCM=nd LCM=nd-12 LCM=0.1-0.4 na
Macrolides:CTR; ERT; RXT
CTR=nd-34; ERT=nd-55; RXT=nd
CTR=nd-34; ERT=nd-10; RXT=nd
CTR=2.9-4.1; ERT=0.8-2.1; RXT=5.4-5.6
na
Quinolones:Other quinolonesFMQ; NLA; OXA
FMQ=nd-7; NLA=nd-17; OXA=nd-5
FMQ=nd-3; NLA=nd-4; OXA=nd-5
FMQ=0.4-1.2; NLA=1.8-2.7; OXA=1.8-2.9
na
Sulfonamides:SDX; SDZ; SMX
SDX=nd; SDZ=nd-28; SMX=nd-372
SDX=nd; SDZ=nd; SMX=nd-25 SDX=0.2-0.5; SDZ=1.4-1.8; SMX=0.5-0.8
na
(Mendoza et al. 2015)
HWWTPE (Valencia)
Diaminopyrimidine:TMT
Min-max HWWTPE:TMT=1,596-4,791
SPE-LC-(QqQ-LIT)MS/MS
TMT=0.6 TMT=2.2
Macrolide:CTR
CTR=78-498 CTR=0.5 CTR=1.8
Quinolone:FluoroquinoloneOFX
OFX=1,547-4,778 OFX=3.7 OFX=12.5
Sulfonamides:SDZ; SMZ
SDZ=9-137; SMZ=nd SDZ=4.4; SMZ=4.9
SDZ=14.6; SMZ=16.6
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
(González et al. 2015)
SeaW (Mar Menor Lagoon; Mediterranean Sea)
Diaminopyrimidine:TMT
Max SeaW:TMT=<LOQ-1.5
SPE-UPLC-(QqQ-LIT)MS/MS
TMT=0.1 TMT=0.4
Macrolides:AZT; CTR; ERT
AZT=nd-163.8; CTR=nd-9.6; ERT=nd-78.4 AZT, CTR, ERT=3.3
AZT, CTR, ERT=11.2
Nitroimidazoles:DTZ; RND
DTZ, RND=nd DTZ=6.5; RND=0.6
DTZ=21.7; RND=2.1
Sulfonamide:SMX
SMX=nd-94 SMX=0.3 SMX=0.9
(Osorio et al. 2015)
RW (Llobregat, Ebro, Júcar, and Guadalquivir Rivers)
β-lactam: CephalosporinCLX
Min-max RW:CLX=nd-1.40
SPE-UPLC-(QqQ-LIT)MS/MS
CLX=0.24 CLX=0.80
Diaminopyrimidine:TMT
TMT=0.03-150.43 TMT=0.10 TMT=0.34
Macrolides:AZT; CTR; ERT
AZT=0.09-153.72; CTR=0.09-65.63; ERT=nd-18.58 AZT=0.05; CTR=0.05; ERT=0.13
AZT=0.18; CTR=0.17; ERT=0.44
Nitroimidazole:DTZ; MND; RND
DTZ=nd-47.41; MND=nd-65.93; RND=nd-7.72 DTZ=1.50; MND=0.57; RND=0.83
DTZ=4.90; MND=1.91; RND=2.76
Quinolones: FluoroquinolonesCPF; OFX
CPF=nd-0.10; OFX=nd-0.07 CPF=0.06; OFX=0.04
CPF=0.19; OFX=0.14
Sulfonamide:SMX
SMX=0.07-41.51 SMX=0.09 SMX=0.31
Tetracycline:TTC
TTC=5.92-27.4 TTC=3.55 TTC=11.83
(Climent et al. 2014)
WWTPI; WWTPE (Salt, Sarrià de Ter; Sant Julià a de Ramis;Aiguaviva; Vilablareix; Fornells de la Selva, Girona); HWWTPE (Dr. Josep Trueta Hospital); RW (Ter River)
Quinolone:FluoroquinoloneCPF
Min-max WWTPI:CPF=1,172-1,558
WWTPE:CPF=36-104
HWWTPE:3,089-14,826
RW:7-103
SPE-UPLC-(QqQ-LIT)MS/MS
CPF=0.6-2.4 CPF=2.0-8.2
(Collado et al. 2014)
WWTPI; WWTPE (Celrà, Catalonia); RW (Ter River)
β-lactam: CephalosporinCLX
Mean (WWTPI; WWTPE)Min-max (RW)
WWTPI:CLX=nd
WWTPE:CLX=nd
RW:CLX=nd
SPE-UPLC-(QqQ-LIT)MS/MS
CLX=1.1-8.0 CLX=3.8-26.8
Diaminopyrimidine:TMT
TMT=54 TMT=7 TMT=nd-9 TMT=0.6-7.1 TMT=2.0-20.0
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Macrolides:AZT; CTR; ERT
AZT=129; CTR=100; ERT=15
AZT=143; CTR=99; ERT=18
AZT=nd-43; CTR=nd-19; ERT=nd-<LOQ
AZT=0.1-2.0; CTR=0.6-3.1; ERT=1.1-2.1
AZT=0.5-6.6; CTR=1.9-10.4; ERT=3.5-6.9
Nitroimidazole:DTZ; MND; RND
DTZ, MND, RND=nd
DTZ, MND, RND=nd
DTZ, MND, RND=nd
DTZ=4.4-20.0; MND=2.7-50.0; RND=2.5-17.0
DTZ=15.0-68.0; MND=8.5-70.0; RND=8.3-53.0
Quinolones: FluoroquinolonesCPF; OFX
CPF=392; OFX=128 CPF=176; OFX=118 CPF=nd-36; OFX=nd-33
CPF=5.5-10.0; OFX=0.6-3.7
CPF=18.3-35.0; OFX=1.8-12.1
Sulfonamide:SMX
SMX=70 SMX=10 SMX=nd-16 SMX=2.0-7.1 SMX=6.5-23.7
Tetracycline:TTC
TTC=nd TTC=nd TTC=nd TTC=7.0-26.0 TTC=23.0-60.0
(González et al. 2014)
RW (El Albujón River)
Diaminopyrimidine:TMT
Min-max RW:TMT=1.1-24.8
SPE-UPLC-(QqQ-LIT)MS/MS
na TMT=0.1-30
Macrolides:AZT; CTR; ERT
AZT=nd-16,633; CTR=nd-2,403; ERT=nd-65.1 na AZT, CTR, ERT=0.1-30
Nitroimidazole:DTZ; MND
DTZ=nd-28; MND=nd-<LOQ na DTZ, MND=0.1-30
Sulfonamide:SMX
SMX=1.1-65.2 na SMX=0.1-30
(Molina et al. 2014)
RW (Guadalquivir and tributaries Rivers); WLW (Santisteban; Ardal; Casillas; Castillo; Orcera; Hituelo; Quinta; Perales; Naranjeros y Rompisaco; Argamasilla); ResW (Giribaile; Quiebrajano; Rumblar La Fernandina; Guadalén)
Amphenicols:CRP; TAP
Max RW:CRP, TAP=nd
WLW:CRP, TAP=nd
ResW:CRP, TAP=nd
SPE-LC-(TOF)MS na na
β-lactams: CephalosporinCTXPenicillins CXC; DXC; OXC; PNG
CTX, CXC, DXC, OXC, PNG=nd
CTX, CXC, DXC, OXC, PNG=nd
CTX, CXC, DXC, OXC, PNG=nd
na na
Diaminopyrimidine:TMT
TMT=nd TMT=nd TMT=nd TMT=1.7 TMT=5.7
Lincosamide:LCM
LCM=2,694.5 LCM=nd LCM=nd-15.9 LCM=0.3 LCM=0.9
Macrolides:CTR; ERT; RXT; TLS
CTR, ERT, RXT, TLS=nd
CTR, ERT, RXT, TLS=nd
CTR=nd; ERT=nd-249.7; RXT=nd; TLS=nd
CTR=na; ERT=6.0; RXT=na; TLS=na
CTR=na; ERT=20.0; RXT=na; TLS=na
Nitroimidazole:MND
MND=nd MND=nd MND=nd na na
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Quinolones:FluoroquinolonesDNF; ENX; ERF; LMF; NOF ; OFX; SRFOther quinolonesFMQ; OXA; SPR
DNF, ENX, ERF, LMF, NOF , OFX, SRF, FMQ, OXA, SPR=nd
DNF, ENX, ERF, LMF, NOF , OFX, SRF, FMQ, OXA, SPR=nd
DNF, ENX, ERF, LMF, NOF , OFX, SRF, FMQ, OXA, SPR=nd
na na
Sulfonamides:SCP; SDM; SDZ; SMR; SMT; SMX; SNL; SPD; STA
SCP, SDM, SDZ, SMR, SMT, SMX, SNL, SPD, STA=nd
SCP, SDM, SDZ, SMR, SMT, SMX, SNL, SPD, STA=nd
SCP, SDM, SDZ, SMR, SMT, SMX, SNL, SPD, STA=nd
na na
Tetracyclines:CTC; DXC; DMC; OXT; TTC
CTC, DXC, DMC, OXT, TTC=nd
CTC, DXC, DMC, OXT, TTC=nd
CTC, DXC, DMC, OXT, TTC=nd
na na
(Boleda et al. 2013)
RW (Llobregat River, Catalonia); WTPE
β-lactam: Penicillin AMX
Min-max RW:AMX=nd
WTPE:AMX=nd
SPE-UPLC-(QqQ)MS/MS
na AMX=110-115
Diaminopyrimidine:TMT
TMT=nd-81 TMT=nd na TMT=0.9-1.1
Lincosamide:LCM
LCM=nd LCM=nd na LCM=0.9
Macrolides:AZT; CTR ; ERT; RXT; TLS
AZT=nd-18; CTR=2-54; ERT=0.8-40; RXT=nd; TLS=nd
AZT=nd; CTR=nd; ERT=nd-2; RXT=nd; TLS=nd
na AZT=0.9-1.0; CTR=0.2; ERT=0.2; RXT=0.2;
Sulfonamides:SDM; SMX; SMZ
SDM=nd-43; SMX=13-149; SMZ=nd-113
SDM, SMX, SMZ=nd na SDM=0.8; SMX=1.0-1.1; SMZ=0.7
Tetracyclines:CTC; TTC
CTC, TTC=nd CTC, TTC=nd na CTC=230-240; TTC=105-110
(Gros et al. 2013)
WWTPI; WWTPE (Girona); HWWTPE (Dr. Josep Trueta Hospital); RW (Onyar River)
β-lactams: Cephalosporins CLX; CPR; CRX; CTF; CTX; CZL Penicillins AMP; AMX; OXC; PNG; PNV
Min-max WWTPI:CLX, CPR, CRX, CTF, CTX, CZL, AMP, AMX, OXC, PNG, PNV=nd
WWTPE:CLX=nd; CPR=nd; CRX=nd; CTF=nd; CTX=nd; CZL=nd; AMP=nd; AMX=nd-258; OXC=nd; PNG=nd; PNV=nd
HWWTPE:CLX, CPR, CRX, CTF, CTX, CZL, AMP, AMX, OXC, PNG, PNV=nd
RW:CLX=nd; CPR=nd; CRX=nd; CTF=nd; CTX=nd; CZL=nd; AMP=nd; AMX=nd-175; OXC=nd; PNG=nd; PNV=nd
SPE-UHPLC-(QqQ-LIT)MS/MS
CLX=0.77-4.32; CPR=2.37-18.54; CRX=5.48-26.90; CTF=1.26-8.31; CTX=2.82-22.52; CZL=13.37-54.11; AMP=0.83-4.56; AMX=1.32-9.49; OXC=34.63-49.43; PNG=2.55-8.62; PNV=5.37-22.82
CLX=2.56-14.41; CPR=7.90-61.80; CRX=18.27-89.67; CTF=4.19-27.71; CTX=9.41-75.06; CZL=44.58-180.37; AMP=2.76-15.20; AMX=4.38-31.63; OXC=115.43-164.75; PNG=8.51-28.73; PNV=17.89-76.08
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Diaminopyrimidine:TMT
TMT=<LOQ-108
TMT=<LOQ-178
TMT=50-216 TMT=nd-28 TMT=1.71-11.50 TMT=5.70-38.34
Lincosamide:CDM; LCM
CDM=14-37; LCM=nd
CDM=18-57; LCM=nd-100
CDM=184-1,465; LCM=nd-119
CDM=2.0-25; LCM=nd
CDM=0.48-4.89; LDM=6.04-17.82
CDM=1.61-16.29; LDM=20.15-59.40
Macrolides:AZT; CTR; RXT; SPR; TLS; TMC
AZT=nd-437; CTR=185-632; RXT=nd-<LOQ; SPR=nd; TLS=nd; TMC=nd
AZT=184-592; CTR=172-229; RXT=nd; SPR=nd; TLS=nd; TMC=nd
AZT=85-113; CTR=113-973; RXT=nd; SPR=nd; TLS=nd; TMC=nd
AZT=10-130; CTR=15-125; RXT=2.0-5.0; SPR=nd; TLS=nd; TMC=nd
AZT=0.61-4.63; CTR=0.35-16.64; RXT=0.31-8.71; SPR=3.99-26.41; TLS=2.37-34.00; TMC=3.73-17.82
AZT=2.05-15.45; CTR=1.18-55.47; RXT=1.04-29.04; SPR=13.29-88.05; TLS=7.90-113.35; TMC=12.44-59.39
Nitroimidazole:MND
MND=17-83 MND=28-316 MND=67-643 MND=25-28 MND=0.43-6.49 MND=1.44-21.64
Quinolones:FluoroquinolonesCPF; DNF; ERF; MBF; NOF; OBF; OFXOther quinolonesCNO; FMQ; NLA; OXA; PPA
CPF=185-613; DNF=nd; ERF=nd-52; MBF=nd-39; NOF=nd-327; OBF=nd; OFX=73-524; CNO=nd; FMQ=nd-<LOQ; NLA=nd; OXA=nd; PPA=nd
CPF=nd-147; DNF=nd; ERF=nd-58; MBF=nd-96; NOF=nd-385; OBF=nd; OFX=63-101; CNO=nd; FMQ=nd-<LOQ; NLA=nd; OXA=nd; PPA=nd-<LOQ
CPF=5,329-7,494; DNF=nd; ERF=nd; MBF=nd; NOF=nd-107; OBF=nd; OFX=2,978-10,368; CNO=nd; FMQ=nd-<LOQ; NLA=<LOQ; OXA=nd; PPA=nd
CPF=nd-250; DNF=nd; ERF=nd-30; MBF=nd; NOF=nd-30; OBF=nd; OFX=15-55; CNO=nd; FMQ=10-15; NLA=nd; OXA=nd; PPA=nd
CPF=1.71-13.58; DNF=11.93-47.43; ERF=0.54-8.42; MBF=2.23-4.31; NOF=2.53-77.71; OBF=0.65- .82; OFX=2.54-15.70; CNO=1.80-15.64; FMQ=0.73-4.25; NLA=1.71-10.56; OXA=2.45-19.60; PPA=3.31-16.87
CPF=5.70-34.51 DNF=39.78-158.11; ERF=1.81-28.06; MBF=7.45-14.37; NOF=8.44-272.50; OBF=2.17-12.75; OFX=8.47-52.32; CNO=6.00-40.83; FMQ=2.44-14.15; NLA=5.71-35.19; OXA=8.15-65.34; PPA=7.40-56.24
Sulfonamides:SBZ; SDM; SDZ; SMP; SMR; SMT; SMX; SNT; SPD; SSD; SSX; STA
SBZ=nd; SDM=nd; SDZ=nd; SMP=nd; SMR=nd; SMT=nd; SMX=43-528; SNT=nd; SPD=<LOQ-159; SSD=nd; SSX=nd; STA=nd
SBZ=nd; SDM=nd; SDZ=nd; SMP=nd; SMR=nd; SMT=nd; SMX=19-198; SNT=nd; SPD=nd-98; SSD=nd; SSX=nd; STA=nd
SBZ=nd; SDM=nd; SDZ=nd; SMP=nd; SMR=nd; SMT=nd; SMX=65-200; SNT=nd; SPD=nd-<LOQ; SSD=nd; SSX=nd; STA=nd
SBZ=nd; SDM=nd-2; SDZ=nd; SMP=nd; SMR=nd; SMT=nd; SMX=10-45; SNT=nd; SPD=nd-25; SSD=nd; SSX=nd-5; STA=nd
SBZ=0.75-3.06; SDM=0.41-16.17; SDZ=3.35- 1.25; SMP=0.81-7.97; SMR=2.37-19.24; SMT=5.16-18.00; SMX=1.39-8.07; SNT=5.16-16.86; SPD=1.82-4.33; SSD=5.16-17.58; SSX=0.87-6.62; STA=2.03-14.40
SBZ=2.50-10.21; SDM=1.38-53.90; SDZ=11.16-37.49; SMP=2.69-26.56; SMR=7.90-64.14; SMT=17.21-51.82; SMX=2.60-26.88; SNT=17.20-56.21; SPD=6.00-14.43; SSD=17.21-51.82; SSX=2.90-22.08; STA=6.70-48.00
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Tetracyclines:CTC; DXC; OXT; TTC
CTC=nd; DXC=nd; OXT=nd; TTC=nd-<LOQ
CTC=nd; DXC=nd; OXT=nd; TTC=nd-<LOQ
CTC, DXC, OXT, TTC=nd
CTC, DXC, OXT, TTC=nd
CTC=11.20-24.02; DXC=9.79-77.49; OXT=3.75-6.01; TTC=4.72-24.30
CTC=37.35-80.06; DXC=37.43-258.29; OXT=12.51-20.05; TTC=15.72-81.00
(Iglesias et al. 2013)
RW (Miño River, Galician)
Diaminopyrimidine:TMT
Min-max RW:TMT=1.1-85.4
SPE-HPLC-MS/MS TMT=0.2 TMT=0.5
Sulfonamides:SMP; SMX
SMP=0.5-11.2; SMX=0.5-63.6 SMP=0.1; SMX=0.2
SMP, SMX=0.5
(Cabeza et al. 2012)
WWTPE (Depurbaix); GW (Llobregat River Aquifer)
Macrolide:ERT
Mean WWTPE:ERT=24-39
GW:ERT=nd-154.33
LC-(Q-IT)MS/MS na na
Quinolones:FluoroquinolonesCPF; OFX
CPF=nd-52; OFX=158-341 CPF=14-323.75; OFX=nd-6 na na
Sulfonamides:SMX; SMZ; SPD
SMX=56-102.25; SMZ=3-74.33; SPD=21-54
SMX=9-46; SMZ=23.16-83.9; SPD=16.5-21.33
na na
(Galán et al. 2012)
WWTPI; WWTPE (22 locations Catalonia)
Sulfonamides:SBZ; SDM; SDX; SDZ; SMP; SMR; SMT; SMX; SMZ; SNT; SPD; SQN; SSD; SSX; STA
Min-max WWTPI:SBZ=0.4-1.17; SDM=0.35-4.92; SDX=nd-1; SDZ=49.1-1,240; SMP=39.6-518; SMR=2.13-7.37; SMT=2.92-33.7; SMX=17.4-665; SMZ=3.36-145; SNT=32.1-62.3; SPD=12.2-3,270; SQN=3.81-210; SSD=nr; SSX=0.607-2.87; STA=7.31-142
WWTPE:SBZ=nd-29.9; SDM=0.08-1.58; SDX=0.1-0.47; SDZ=8.75-286; SMP=0.223-47; SMR=0.205-1.93; SMT=1.06-70.7; SMX=10.8-284; SMZ=0.458-36.4; SNT=17-512; SPD=3.35-177; SQN=0.246-14.6; SSD=1.7-6.52; SSX=0.3-1.18; STA=0.7-73
SPE-LC-(QqQ-LIT)MS/MS
SBZ=0.01-0.20; SDM=0.01-0.02; SDX=0.11-0.16; SDZ=0.40-1.38; SMP=0.08-0.71; SMR=0.12-0.61; SMT=0.16-0.57; SMX=0.16-0.19; SMZ=0.19-2.35; SNT=0.06-0.26; SPD=0.24-0.98; SQN=0.04-0.15; SSD=nr-0.05; SSX=0.13-0.18; STA=0.21-0.24
SBZ=0.03-0.66; SDM=0.02-0.08; SDX=0.38-0.54; SDZ=1.32-4.58; SMP=0.27-2.38; SMR=0.39-2.05; SMT=0.53-1.91; SMX=0.54-0.64; SMZ=0.62-7.83; SNT=0.20-0.86; SPD=0.79-3.27; SQN=0.14-0.49; SSD=nr-0.18; SSX=0.44-0.60; STA=0.69-0.81
(Gros et al. 2012)
WWTPI; WWTPE (Girona, Catalonia); RW (Onyar and Ter Rivers); ResW (Foix); DW (Girona, Catalonia); SeaW (Mediterranean Sea)
β-lactam:Cephalosporin CLX
Min-max WWTPI:CLX=nd
WWTPE:CLX=nd
RW:CLX=nd
ResW:CLX=nd
DW:CLX=nr
SeaW:CLX=nr
SPE-UPLC-(QqQ-LIT)MS/MS
CLX=nr-8.0 CLX=nr-35.0
Diaminopyrimidine:TMT
TMT=11-204
TMT=nd-100
TMT=3-9
TMT=nd
TMT=nd TMT=1 TMT=0.1-7.1 TMT=0.3-20.0
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Macrolides:AZT; CTR; ERT
AZT=44-205; CTR=55-459; ERT=35-63
AZT=20-170; CTR=<LOQ-192; ERT=<LOQ-17
AZT=1-41; CTR=<LOQ-59; ERT=nd-<LOQ
AZT, CTR, ERT=nd
AZT=<LOQ; CTR=nd; ERT=nd
AZT=<LOQ; CTR=17; ERT=nd
AZT=0.1-2.0; CTR=0.4-3.1; ERT=0.2-2.1
AZT=0.5-6.6; CTR=1.3-10.4; ERT=0.5-6.9
Nitroimidazoles:DTZ; MND; RND
DTZ=nd; MND=152; RND=nd
DTZ=nd; MND=121; RND=nd
DTZ, MND, RND=nd
DTZ, MND, RND=nd
DTZ=nd; MND=nr; RND=nd
DTZ, MND, RND=nd
DTZ=1.0-20.0; MND=nr-50.0; RND=0.5-17.0
DTZ=2.8-68.0; MND=nr-70.0; RND=1.8-53.0
Quinolones:FluoroquinolonesCPF; OFX
CPF=230-252; OFX=202-309
CPF=87-245; OFX=169-191
CPF=<LOQ-23; OFX=20-33
CPF=nd; OFX=6
CPF, OFX=nr
CPF=nr; OFX=2
CPF=nr-10.0; OFX=nr-3.7
CPF=nr-35.0; OFX=nr-12.1
Sulfonamide:SMX
SMX=nd-768
SMX=nd-222
SMX=10-79
SMX=4 SMX=0.5
SMX=9 SMX=0.1-7.1 SMX=0.3-23.7
Tetracycline:TTC
TTC=nd TTC=nd TTC=nd-<LOQ
TTC=nd TTC=nd TTC=nd TTC=7.0-26.0 TTC=20.0-60.0
(Lor et al. 2012) WWTPI; WWTPE (Castellon de la Plana; Benicassim; Burriana)
Amphenicol:CRP
Min-max WWTPI:CRP=nd
WWTPE:CRP=nd
SPE-UHPLC-(QqQ)MS/MS
na CRP=20-30
Diaminopyrimidine:TMT
TMT=60-160 TMT=60-100 na TMT=10-40
Lincosamide:CDM; LCM
CDM=nd; LCM =100-880 CDM=10-20; LCM=10-160 na CDM=6-40; LCM=2-10
Macrolides:CTR; ERT; RXT; TLS
CTR=130-620; ERT=nd; RXT=nd; TLS=nd
CTR=10-60; ERT=50-120; RXT=<LOQ; TLS=nd
na CTR=3-10; ERT=8-20; RXT=20-30; TLS=2-10
Quinolones:FluoroquinolonesCPF; ERF; MBF; MXF; NOF; OFX; PEF; SRF Other quinolonesFMQ; NLA; OXA; PPA
CPF=1,210–3,850; ERF=nd; MBF=nd; MXF=nd; NOF=290-1,070; OFX=290-960; PEF=nd; SRF=nd; FMQ=nd; NLA=nd; OXA=nd; PPA=<LOQ-540
CPF=520-1,080; ERF=nd; MBF=nd; MXF=120-180; NOF=90-150; OFX=330-500; PEF=nd; SRF=nd; FMQ=nd; NLA=nd; OXA=nd; PPA=<LOQ-120
na CPF=50-320; ERF=20-40; MBF=110-120; MXF=110-330; NOF=30-160; OFX=10; PEF=50-80; SRF=30-40; FMQ=10-60; NLA=6-20; OXA =10-20; PPA=90-210
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Sulfonamides:SDZ; SMX; SMZ; STA
SDZ=nd; SMX =220-640; SMZ=nd; STA=60-70
SDZ=nd; SMX =40-60; SMZ=nd; STA=nd
na SDZ=50-80; SMX=10-20; SMZ=1-3; STA=10-40
(Osorio et al. 2012)
RW (LlobregatRiver)
Amphenicol:CRP
Min-max RW:CRP=nd-1.36
SPE-LC-(QqQ-LIT)MS/MS
na na
Diaminopyrimidine:TMT
TMT=nd-35.56 na na
Macrolides:AZT; CTR; ERT; JSM; RXT; SPR; TLS; TMC
AZT=nd-37.46; CTR=nd-232.13; ERT=0.02-362.49; JSM=0.01-11.09; RXT=nd-8.11; SPR=0.04-152.09; TLS=nd-30.27; TMC=nd-95.77
na na
Nitroimidazoles:MND
MND=nd-48.8 na na
Quinolones:FluoroquinolonesCPF; DNF; ENX; ERF; NOF; OFX
CPF=0.56-271.04; DNF=nd-279.89; ENX=nd-279.19; ERF=nd-313.21; NOF=0.73-404.8; OFX=nd-488.38
na na
Sulfonamides:SDZ; SMX; SMZ
SDZ=0.06-106.67; SMX=0.21-1,500; SMZ=nd-280.9 na na
Tetracyclines:CTC; DXC; OXT; TTC
CTC=<LOQ-11.23; DXC=nd-18.16; OXT=nd-81.6; TTC=nd-712.4 na na
(Roig et al. 2012)
RW (Pego–Oliva Marsh)
Diaminopyrimidine:TMT
Min-max RW:TMT=nd-2.97
SPE-LC-(QqQ)MS/MS
na na
Quinolones:FluoroquinolonesCPF; NOF; OFX
CPF=nd-34.6; NOF=nd-37.16; OFX=nd-50.19 na CPF=12; NOF=9.6; OFX=8.1
Sulfonamide:SMX
SMX=nd-15.58 na SMX=0.9
Tetracyclines:OXT; TTC
TTC, OXT=nd na TTC=10; OXT=9.4
(Serna et al. 2012)
RW (Ebro River and tributaries)
Amphenicol:CRP
Min-max RW:CRP=nd
SPE-LC-(QqQ)MS/MS
CRP=<10 na
Diaminopyrimidine:TMT
TMT=nd-59.9 TMT=<10 na
Macrolides:AZT; CTR; JSM; RXT
AZT=nd-41.1; CTR=6.12-141; JSM=nd; RXT=nd AZT, CTR, JSM, RXT
na
Nitroimidazole:MND
MND=nd-<LOQ MND=<10 na
Quinolones:FluoroquinolonesCPF; DNF; ENX; NOF; OFXOther quinolone:FMQ
CPF=nd-<LOQ; DNF=nd-<LOQ; ENX=nd-<LOQ; NOF=nd; OFX=nd-79.9; FMQ=nd-<LOQ
CPF, DNF, ENX, NOF, OFX, FMQ=<10
na
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Sulfonamides:SDZ; SMX; SMZ
SDZ=<LOQ-136; SMX=nd-17.2; SMZ=nd-641 SDZ, SMX, SMZ=<10
na
(Galán et al. 2011)
RW (Ebro River) Sulfonamides:SBZ; SDM; SDX; SDZ; SMP; SMR; SMT; SMX; SMZ; SNT; SPD; SQN; SSD; SSX; STA
Min-max RW:SBZ=1.8–14.6; SDM=0.5–23.1; SDX=2.7–43.3 ; SDZ=0.7–6.4; SMP=0.6–18.1; SMR=1-42.2; SMT=2.3–4.6; SMX=0.2–35.6; SMZ=2.5–65.2; SNT=nd–127; SPD=0.1–42.5; SQN=4.5–40.4; SSD=1-40.4; SSX=0.1–12.5; STA=1.5–9.6
SPE-LC-(QqQ-LIT)MS/MS
SBZ=0.05; SDM=0.13; SDX=0.21; SDZ=0.39; SMP=0.11; SMR=1.53; SMT=0.37; SMX=1.11; SMZ=0.12; SNT=0.46; SPD=0.27; SQN=0.59; SSD=0.10; SSX=0.51; STA=0.23
SBZ=0.15; SDM=0.45; SDX=0.69; SDZ=1.29; SMP=0.38; SMR=5.11; SMT=1.24; SMX=3.69; SMZ=0.40; SNT=1.53; SPD=0.91; SQN=1.97; SSD=0.32; SSX=1.71; STA=0.77
(Lor et al. 2011) WWTPE; SW (Castellon; Valencia)
Amphenicol:CRP
Max WWTPE:CRP=nd
SW:CRP=nd
SPE-UHPLC-(QqQ)MS/MS
na CRP=7-19
Diaminopyrimidine:TMT
TMT=232 TMT=151 na TMT=2-9
Lincosamide:CDM; LCM
CDM=nd; LCM=142 CDM=nd; LCM=47 na CDM=1-6; LCM=2-2
Macrolides:CTR; ERT; RXT; TLS
CTR=247; ERT=82; RXT=18; TLS=nd
CTR=91; ERT=78; RXT=12; TLS=nd
na CTR=2-3; ERT=0.4-8; RXT=2-17; TLS=0.7-2
Quinolones:FluoroquinolonesCPF; ERF; MBF; MXF; NOF; OFX; PEF; SRF Other quinolonesFMQ; NLA; OXA; PPA
CPF=2,292; ERF=220; MBF=540; MXF=nd; NOF=310; OFX=925; PEF=112; SRF=52; FMQ=41; NLA=60; OXA=nd; PPA=430
CPF=740; ERF=70; MBF=205; MXF=nd; NOF=54; OFX=400; PEF=64; SRF=55; FMQ=20; NLA=14; OXA=23; PPA=245
na CPF=18-46; ERF=9-21; MBF=19-110; MXF=55-114; NOF=11-25; NOF=2-13; PEF=13-50; SRF=10-25; FMQ=2-9; NLA=3-6; OXA=2-10; PPA=36-91
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Sulfonamides:SDZ; SMX; SMZ; STA
SDZ=nd; SMX=432; SMZ=11; STA=30
SDZ=nd; SMX=33; SMZ=nd; STA=nd
na SDZ=4-45; SMX=3-13; SMZ=0.5-0.8; STA=2-9
(Serna et al. 2011)
RW (Ebro River) Amphenicol:CRP
Min-max RW:CRP=<LOQ
SPE-UHPLC-(QqQ)MS/MS
CRP=0.13 CRP=0.43
Diaminopyrimidine:TMT
TMT=<LOQ-29.90 TMT=0.11 TMT=0.38
Macrolides:AZT; CTR; ERT; JSM; RXT; SPR ; TLS; TMC
AZT=<LOQ-36.70; CTR=<LOQ-36.93; ERT=<LOQ-51.60; JSM=<LOQ-0.52; RXT=<LOQ-0.32; SPR=<LOQ-488.0; TLS=<LOQ-0.77; TMC=<LOQ-227.0
AZT=2.29; CTR=0.74; ERT=8.36; JSM=0.69; RXT=0.48; SPR=3.38; TLS=9.41; TMC=0.15
AZT=7.65; CTR=2.48; ERT=27.87; JSM=2.28; RXT=1.59; SPR=11.27; TLS=31.37; TMC=0.50
Nitroimidazole:MND
MND=nd-30.20 MND=0.64 MND=2.14
Quinolones:FluoroquinolonesCPF; DNF; ENX; ERF; NOFOFXOther quinoloneFMQ
CPF=<LOQ-115.0; DNF=<LOQ-207.0; ENX=<LOQ-140.0; ERF=13.10-178.0; NOF=<LOQ-89.80; OFX=4.84-105.0; FMQ=<LOQ-30.29
CPF=7.95; DNF=1.17; ENX=53.97; ERF=17.17; NOF=38.01; OFX=1.51 FMQ=1.03
CPF=26.51; DNF=3.89; ENX=179.89; ERF=57.22; NOF=126.68; OFX=5.05; FMQ=3.42
Sulfonamides:SDZ; SMX; SMZ
SDZ=<LOQ-23.48; SMX=<LOQ-55.01; SMZ=<LOQ SDZ=0.41; SMX=0.97; SMZ=1.10
SDZ=1.36; SMX=3.23; SMZ=3.66
Tetracyclines:CTC; DXC; OXT; TTC
CTC=<LOQ-59.30; DXC=<LOQ-47.70; OXT=<LOQ-37.10; TTC=<LOQ-228.0
CTC=2.40; DXC=1.39; OXT=3.60; TTC=1.43
CTC=7.99; DXC=4.63; OXT=12.01; TTC=4.77
(Silva et al. 2011)
WWTPE (Tudela; Lleida; Logroño; Zaragoza; Tudela; Pamplona; Tortosa); RW (Ebro River)
Amphenicol:CRP
Min-max WWTPE:CRP=nd
RW:CRP=nd-<LOQ
SPE-LC-(QqQ-LIT)MS/MS
CRP=0.02-0.66 CRP=0.1-2
Diaminopyrimidine:TMT
TMT=16.4-249 TMT=nd-29.9 TMT=0.2-0.4 TMT=0.8-1
Macrolides:CTR; ERT; JSM; RXT; TLS
CTR=19.8-212; ERT=nd-24.5; JSM=nd-18.9; RXT=nd-63.8; TLS=nd-266.9
CTR=<LOQ-36.9; ERT=nd-42.4; JSM=nd-0.52; RXT=nd; TLS=nd-<LOQ
CTR=0.5-4; ERT=0.4-1.8; JSM=1; RXT=0.5-1;TLS=1-2
CTR=2-15; ERT=0.6-6; JSM=2-5; RXT=2; TLS=4
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Nitroimidazole:MND
MND=20.4-138 MND=nd-30.2 MND=0.3-0.7 MND=1-2
Sulfonamides:SDZ; SMZ
SDZ=nd; SMZ=nd-26.8 SDZ=nd-<LOQ; SMZ=nd-<LOQ SDZ=0.4-2; SMZ=0.8-1
SDZ=2-5; SMZ=1.6-3
(Valcárcel et al. 2011)
RW (Jarama, Manzanares, Guadarrama,Henares, and Tagus Rivers)
Diaminopyrimidine:TMT
Min-max RW:TMT=38-690
SPE-LC-(Q-IT)MS/MS
na TMT=2
Macrolides:AZT; CTR; ERT
AZT=<LOQ-569; CTR=132-1,727; ERT=<LOQ-3,847 na AZT=13; CTR=6; ERT=1
Nitroimidazole:MND
MND=<LOQ-1,834 na MND=3
Quinolones:FluoroquinolonesCPF; NOF; OFX
CPF=<LOQ-224; NOF=<LOQ; OFX=<LOQ-552 na CPF=6; NOF=10; OFX=3
Sulfonamide:SMX
SMX=32-952 na SMX=1
Tetracycline:TTC
TTC=<LOQ na TTC=23
(Galán, Cruz, et al. 2010)
WWTPI; WWTPE (Catalonia); RW (Ebro River); GW (Catalonia)
Sulfonamides:SBZ; SCT; SDM; SDX; SDZ; SGD; SMP; SMR; SMT; SMX; SMZ; SNT; SPD; SQN; SSD; SSX; STA
Min-max WWPI:SBZ=nd; SCT=nd; SDM=nd-20.1; SDX=nd-<LOQ; SDZ=nd-181; SGD=nd-<LOQ; SMP=nd; SMR=nd; SMT=nd-247; SMX=nd-89; SMZ=nd; SNT=nd-<LOQ; SPD=<LOQ-855; SQN=nd; SSD=nd; SSX=nd<LOQ; STA=nd-37.5
WWTPE:SBZ=nd-<LOQ; SCT=nd; SDM=nd-10; SDX=nd-<LOQ; SDZ=nd-104; SGD=nd-1.88; SMP=nd; SMR=nd-34.6; SMT=nd-<LOQ; SMX=12.4-302; SMZ=nd-18; SNT=nd; SPD=<LOQ-133; SQN=nd-<LOQ; SSD=nd-<LOQ; SSX=nd-8.17; STA=nd-9.21
RW:SBZ=nd-1.78; SCT=nd; SDM=nd-18.01; SDX=nd-20.00; SDZ=nd; SGD=nd; SMP=nd-15.50; SMR=nd-15.50; SMT=nd-2.65; SMX=nd-32.20; SMZ=nd-20.10; SNT=nd; SPD=0.16-11.20; SQN=nd-20.80; ; SD=nd-3.70; SSX=nd-12.50; STA=nd-13.90
GW:SBZ=nd-3.41; SCT=nd-<LOQ; SDM=nd-1.65; SDX=nd-4.48; SDZ=nd-0.81; SGD=nd; SMP=nd-0.77; SMR=nd-3.22; SMT=nd-<LOQ; SMX=nd-63.90; SMZ=nd-3.71; SNT=nd-0.82; SPD=nd-1.11; SQN=nd-1.17; SSD=nd-1.89; SSX=nd-<LOQ; STA=nd
SPE-LC-(Q-IT)MS/MS
SBZ=0.05-0.41; SCT=4.06-6.90; SDM=0.01-0.16; SDX=0.02-0.19; SDZ=0.18-1.12; SGD=1.01-12.00; SMP=0.03-0.14; SMR=0.12-0.25; SMT=1.04-4.52; SMX=0.77-1.14; SMZ=0.04-0.40; SNT=0.03-0.56; SPD=0.02-0.32; SQN=0.02-0.55; SSD=0.03-0.13; SSX=0.31-2.15; STA=0.21-0.45
SBZ=0.17-1.38; SCT=13.50-23.00; SDM=0.02-0.54; SDX=0.08-0.63; SDZ=0.59-3.72; SGD=3.37-40.00; SMP=0.09-0.47; SMR=0.40-0.83; SMT=3.47-15.10; SMX=2.55-3.79; SMZ=0.13-1.33; SNT=0.10-1.87; SPD=0.05-1.08; SQN=0.08-1.83; SSD=0.11-0.43; SSX=1.03-7.16; STA=0.70-1.48
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
(Galán, Garrido, et al. 2010)
GW (La Plana de Vic; La Selva)
Sulfonamides:SBZ; SCT; SDM; SDX; SDZ; SGD; SMP; SMR; SMT; SMX; SMZ; SNT; SPD; SQN; SSD; SSX; STA
Min-max GW:SBZ=0.09-10.32; SCT=1.77-3,461; SDM=0.01-91.48; SDX=0.02-53.63; SDZ=0.14-6.98; SGD=3.30-91.78; SMP=0.02-68.70; SMR=0.11-744.7; SMT=0.22-9.29; SMX=0.08-312.2; SMZ=0.03-106.8; SNT=0.04-568.8; SPD=0.07-72.45; SQN=0.01-112.1; SSD=0.01-64.40; SSX=0.21-4.43; STA=0.01-16.78
SPE-LC-(QqQ-LIT)MS/MS
SBZ=0.019; SCT=8.876; SDM=0.039; SDX=0.019; SDZ=0.021; SGD=0.796; SMP=0.036; SMR=0.086; SMT=0.366; SMX=0.050; SMZ=0.034; SNT=0.058; SPD=0.023; SQN=0.016; SSD=0.012; SSX=0.049; STA=0.005
SBZ=0.062; SCT=29.586; SDM=0.131; SDX=0.064; SDZ=0.069; SGD=2.653; SMP=0.118; SMR=0.286; SMT=1.221; SMX=0.167; SMZ=0.113; SNT=0.195; SPD=0.077; SQN=0.055; SSD=0.042; SSX=0.140; STA=0.018
(Galán, Villagrasa, et al. 2010)
RW (Llobregat and Anoia Rivers)
Sulfonamides:SDM; SDZ; SMP; SMT; SMX; SMZ; SPD; SSX; STA
Min-max RW:SDM=nd-136.0; SDZ=nd->5,000; SMP=nd->5,000; SMT=nd-10.3; SMX=nd-652.7; SMZ=nd->5,000; SPD=nd->5,000; SSX=nd-24.7; STA=nd-960.6
SPE-LC-(QqQ-LIT)MS/MS
SDM=0.11; SDZ=0.05; SMP=0.05; SMT=0.21; SMX=0.17; SMZ=0.22; SPD=0.16; SSX=0.06; STA=0.13
SDM=0.37; SDZ=0.17; SMP=0.17; SMT=0.70; SMX=0.57; SMZ=0.73; SPD=0.53; SSX=0.20; STA=0.43
(Muñoz et al. 2010)
WWTPE; RW (Doñana Natural Park)
Sulfonamides:SMX
Min-max WWTPE:SMX=nd-1,620
RW:SMX=nd
SPE-HPLC-DAD SMX=8 SMX=28
(Roldán et al. 2010)
RW (Llobregat River)
Diaminopyrimidine:TMT
Min-max RW:TMT=2.4-252.0
SPE-LC-(QqQ)MS/MS
TMT=0.3 TMT=0.5
Macrolide:ERT
ERT=6.9-119.9 ERT=1.6 ERT=2.3
Quinolone:FluoroquinoloneOFX
OFX=8.0-1,903.6 OFX=0.9 OFX=2.3
Sulfonamide:SMX
SMX=4.1-119.3 SMX=0.4 SMX=0.9
(Rosal et al. 2010)
WWTPI; WWTPE (Alcalá de Henares, (Madrid)
Diaminopyrimidine:TMT
Min-max WWTPI:TMT=78-197
WWTPE:TMT=<LOQ-148
SPE-LC-(Q-IT)MS/MS
na TMT=29
Macrolides:ERT
ERT=<LOQ-2,310 ERT=<LOQ-760 na ERT=99
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Nitroimidazole:MND
MND=44-165 MND=<LOQ-127 na MND=17
Quinolones:FluoroquinolonesCPF; OFX
CPF=160-13,625; OFX=848-5,286
CPF=<LOQ-5,692; OFX=<LOQ-1,641
na CPF=10; OFX=33
Sulfonamide:SMX
SMX=162-530 SMX=104-370 na SMX=15
(Serna et al. 2010)
WWTPE (Barcelona); RW (Llobregat River); DW (Barcelona)
Amphenicol:CRP
Mean WWTPE:CRP=nd
RW:CRP=nd
DW:CRP=nd
SPE-LC-(QqQ-LIT)MS/MS
CRP=0.35-1.10 CRP=1.16-3.68
Diaminopyrimidine:TMT
TMT=65.92 TMT=16.43-33.53 TMT=0.51 TMT=0.33-2.81 TMT=1.09-9.37
Macrolides:AZT; CTR; ERT; JSM; RXT; SPR ; TLS; TMC
AZT=1,031.67; CTR=3.90; ERT=677.00; JSM=237.83; RXT=nd; SPR=7.17; TLS=3.03; TMC=141.58
AZT=14.73-71.67; CTR=nd; ERT=50.38-174.73; JSM=88.83-42.60; RXT=nd; SPR=nd; TLS=0.81-1.82; TMC=39.90-68.32
AZT=17.00; CTR=nd; ERT=nd; JSM=3.67; RXT=nd; SPR=nd; TLS=1.41; TMC=20.54
AZT=0.16-2.71; CTR=0.13-0.48; ERT=7.34-10.21; JSM=0.33-0.47; RXT=0.32-10.14; SPR=0.36-1.34; TLS=0.22-0.41; TMC=0.43-1.24
AZT=0.53-9.04; CTR=0.44-1.59; ERT=24.48-34.03; JSM=1.09-1.58; RXT=1.07-33.81; SPR=1.19-4.46; TLS=0.74-1.36; TMC=1.44-4.15
Nitroimidazole:MND
MND=211.83 MND=nd-4.88 MND=nd MND=3.39-43.84 MND=11.29-146.14
Quinolones:FluoroquinolonesCPF; DNF; ENX; ERF; NOFOFXOther quinoloneFMQ
CPF=8.27; DNF=255.67; ENX=63.72; ERF=276.67; NOF=151.25; OFX=nd; FMQ=nd
CPF=4.65-4.83; DNF=5.82-40.12; ENX=15.17-15.83; ERF=23.28-75.017; NOF=8.32-28.02; OFX=nd; FMQ=nd
CPF=16.04; DNF=18.93; ENX=32.88; ERF=15.30; NOF=13.28; OFX=nd; FMQ=nd
CPF=2.47-4.57; DNF=4.41-5.65; ENX=4.88-26.95; ERF=1.15-4.73; NOF=2.09-4.07; OFX=0.60-1.35; FMQ=0.44-3.59
CPF=8.23-15.24; DNF=14.69-18.84; ENX=16.28-89.83; ERF=3.83-15.77; NOF=6.97-13.55; OFX=2.01-4.49; FMQ=1.45-11.96
Sulfonamides:SDZ; SMX; SMZ
SDZ=20.38; SMX=140.48; SMZ=373.84
SDZ=nd-3.40; SMX=39.70-78.38; SMZ=1.68-112.27
SDZ=nd; SMX=nd; SMZ= nd-4.08
SDZ=2.86-73.91; SMX=0.89-2.53; SMZ=0.81-3.88
SDZ=9.54-246.36; SMX=2.97-8.43; SMZ=2.69-12.94
Tetracyclines:CTC; DXC; OXT; TTC
CTC=nd; DXC=nd; OXT=42.12; TTC=171.47
CTC=nd; DXC=nd; OXT=nd; TTC=nd-29.00
CTC, DXC, OXT, TTC=nd
CTC=6.02-11.38; DXC=21.14-23.60; OXT=8.07-12.81; TTC=2.65-6.52
CTC=20.08-37.93; DXC=70.45-78.65; OXT=26.90-42.71; TTC=8.83-21.75
(Muñoz et al. 2009)
WWTPI; WWTPE; RW (Seville)
Diaminopyrimidine:TMT
WWTPI:TMT=nd
WWTPE:TMT=nd
RW:TMT=nd
SPE-HPLC-DAD TMT=8-17 TMT=28-56
Sulfonamide:SMX
SMX=nd SMX=nd SMX=nd SMX=6-12 SMX=20-40
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
(Cruz et al. 2008)
WWTPE (Lleida); RW (Llobregat, Segre, and Anoia Rivers, Barcelona); GW (Barcelona); DW (Bottled mineral water, supermarket)
Sulfonamides:SDM; SDZ; SMP; SMT; SMX; SMZ ; SPD; SSX; STA
Min-max WWTPE:SDM=12; SDZ=34.3; SMP=nr; SMT=48.5; SMX=241.6; SMZ=10.7; SPD=28.8; SSX=1.6; STA=53.7
RW:SDM=1.5-182.4; SDZ=nd-2,312; SMP=nd-3,704; SMT=nd-7; SMX=nd-1,488; SMZ=nd-6,192; SPD=1.2-12,000; SSX=nd-2.8; STA=1.5-38.1
GW:SDM=0.2; SDZ=nd; SMP=<LOQ; SMT=<LOQ; SMX=9.9; SMZ=<LOQ; SPD=<LOQ; SSX=nd; STA=<LOQ
DW:SDM=0.164; SDZ=<LOQ; SMP=<LOQ; SMT=<LOQ; SMX=<LOQ; SMZ=<LOQ; SPD=<LOQ; SSX=<LOQ; STA=<LOQ
SPE-LC-(Q-LIT)MS/MS
SDM=0.01-0.31; SDZ=0.09-1.02; SMP=0.02-0.77; SMT=0.02-0.42; SMX=0.05-1.13; SMZ=0.03-43.09; SPD=0.04-0.18; SSX=0.01-0.29; STA=nr-0.20
SDM=0.05-1.02; SDZ=0.31-3.41; SMP=0.07-2.57; SMT=0.06-1.41; SMX=0.15-3.77; SMZ=0.11-143.65; SPD=0.14-0.62; SSX=0.04-0.97; STA=nr-0.67
(Gros et al. 2007)
RW (Vallas, Ebro, Iregua, Arga, and Segre Rivers)
Diaminopyrimidine:TMT
Min-max RW:TMT=10-69
SPE-LC-(QqQ)MS/MS
TMT=1 TMT=4
Macrolide:AZT; ERT
AZT=9-68; ERT=nd-71 AZT=1; ERT=4 AZT=3; ERT=14
Quinolone:FluoroquinoloneOFX
OFX=nd-146 OFX=16 OFX=56
Sulfonamide:SMX
SMX=22-169 SMX=5 SMX=16
(Gómez et al. 2006)
HWWTPE (Almería) Diaminopyrimidine:TMT
Min-max HWWTPE:TMT=1.8-9.4
SPE-LC-(QqQ)MS/MS
TMT=40 TMT=112
Macrolide:ERT
ERT=0.01-0.03 ERT=9.2 ERT=26
Nitroimidazole:MND
MND=0.01-0.03 MND=3.8 MND=11
(Gros et al. 2006)
RW (Ebro River and tributaries)
Diaminopyrimidine:TMT
Min-max RW:TMT=nd-20
SPE-LC-(QqQ)MS/MS
TMT=1 TMT=4
Macrolide:AZT; ERT
AZT=nd-20; ERT=nd-30 AZT=1; ERT=4 AZT=3; ERT=14
Quinolone:FluoroquinoloneOFX
OFX=nd OFX=16 OFX=56
Sulfonamide:SMX
SMX=nd-<LOQ SMX=5 SMX=16
(Gros et al. 2006)
WWTPI; WWTPE (Rubí)
Diaminopyrimidine:TMT
Min-max WWTPI:TMT=nd-4,220
WWTPE:TMT=70-310
SPE-LC-(QqQ)MS/MS
TMT=10-25 na
Macrolides:ERTAZT
WWTPI:AZT=nd-300; ERT=nd
WWTPE: AZT=50-210; ERT=nd
AZT=1-3; ERT=4-6
na
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Quinolone:FluoroquinoloneOFX
WWTPI:OFX=nd
WWTPE: OFX=nd
OFX=43-43 na
Sulfonamide:SMX
WWTPI:SMX=nd-870
WWTPE: SMX=nd-820
SMX=20-42 na
(Reverté et al. 2003)
WWTPI; WWTPE (Tarragona); RW (Ebro River); WellW
Quinolones:FluoroquinolonesCPF; ERF
WWTPI:CPF, ERF=nd
WWTPE:CPF, ERF=nd
RW:CPF, ERF=nd
WellW:CPF, ERF=nd
SPE-HPLC-MS CPF, ERF=4 na
Tetracycline:CTC; DXC; OXT; TTC
CTC, DXC, OXT, TTC=nd
CTC, DXC, OXT, TTC=nd
CTC, DXC, OXT, TTC=nd
CTC, DXC, OXT, TTC=nd
CTC=6; DXC=6; OXT=4; TTC=4
na
Sweden(Grabic et al. 2012)
WWTPE (Alvesta; Lessebo; Ljungby; Markaryd; Uppvidinge; Älmhult)
Diaminopyrimidine:TMT
Min-max WWTPE:TMT=27-101
SPE-LC-(QqQ)MS/MS
na TMT=0.10
Lincosamide:CDM
CDM=<LOQ-154 na CDM=0.98
Macrolides:AZT; CTR; RXT
AZT=<LOQ; CTR=14-78; RXT=<LOQ na AZT=4.6; CTR=11; RXT=47
Quinolones:FluoroquinolonesCPF; NOF; OFX
CPF=<LOQ-10.5; NOF=<LOQ-10.6; OFX=<LOQ na CPF=0.62; NOF=9.2; OFX=14
Sulfonamide:SMX
SMX=15-203 na SMX=5.1
(Zorita et al. 2009)
WWTPI; WWTPE (Kristianstad); DWWTE; HWWTPE;
Quinolones:FluoroquinolonesCPF; NOF; OFX
WWTPI:CPF=320; NOF=18.0; OFX=22.5
WWTPE:CPF=31.5; NOF=nd; OFX=10.0
DWWTPE:CPF=3,700; NOF=nd; OFX=16.7
HWWTPE:CPF=3,300; NOF=22.0; OFX=840
SPE-LC-(QqQ)MS/MS
CPF=4.9; NOF=5.5; OFX=3.3
na
(Bendz et al. 2005)
WWTPI; WWTPE (Källby); RW (Höje River)
Diaminopyrimidine:TMT
Min-max WWTPI:TMT=80
WWTPE:TMT=40
RW:TMT=<LOQ-40
SPE-LC-MS/MS na na
Sulfonamide:SMX
SMX=20 SMX=70 SMX=<LOQ-50 na na
(R. H. Lindberg et al. 2005)
WWTPI; WWTPE (Stockholm; Gothenburg; Umeå; Floda)
β-lactams: CephalosporinCDXPenicillins AMP; AMX
Min-max WWTPI:CDX, AMP, AMX=nd
WWTPE:CDX, AMP, AMX=nd
SPE-LC-(IT)MS/MS
na CDX=77; AMP=60; AMX=74
Diaminopyrimidine:TMT
TMT=99-1,300 TMT=66-1,340 na TMT=8
Nitroimidazole:MND
MND=nd MND=nd na MND=33
Quinolones: FluoroquinolonesCPF; NOF; OFX
CPF=90-300; NOF=66-174; OFX=<LOQ-287
CPF=<LOQ-60; NOF=<LOQ-37; OFX=<LOQ-52
na CPF=6; NOF=7; OFX=6
Sulfonamide:SMX
SMX=<LOQ-674 SMX=<LOQ-304 na SMX=80
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Tetracycline:DXC
DXC=<LOQ-2,480 DXC=<LOQ 64-915 na DXC=64
(R. Lindberg et al. 2004)
HWWTPE (Kalmar) β-lactams: CephalosporinCDXPenicillins AMP; AMX
Min-max HWWTPE:CDX, AMP, AMX =nd
SPE-LC-(IT)MS/MS
na CDX=42,000; AMP=33,000; AMX =37,000
Diaminopyrimidine:TMT
TMT=<LOQ-7,600 na TMT=1,000
Nitroimidazole:MND
MND=<LOQ-90,200 na MND=13,000
Quinolones: FluoroquinolonesCPF; NOF; OFX
CPF=3,600-101,000; NOF=nd; OFX=<LOQ-7,600 na CPF=3,000; NOF=4,000; OFX=5,000
Sulfonamide:SMX
SMX=<LOQ-13,000 na SMX=68,000
Tetracycline:DXC
DXC=<LOQ na DXC=68,000
(Andreozzi et al. 2003)
WWTPE (Göteborg) Diaminopyrimidine:TMT
Min-max WWTPE:TMT=50
SPE-HPLC-MS/MS na na
Quinolones:FluoroquinolonesCPF; ENX; LMF; NOF; OFX
CPF=30; ENX=10; LMF=130; NOF=30; OFX=120 na na
Sulfonamide:SMX
SMX=20 na na
Swiss(Joss et al. 2005) WWTPE
(Kloten/Opfiko, Zurich; Altenrhein, St. Gall)
Macrolide:RXT
Min-max WWTPE:RTX=9-60
SPE-HPLC-(QqQ)MS/MS
na 0.4-1.4
Sulfonamide:SMX
SMX=98-990 na 6-15
(Göbel et al. 2004)
WWTPE (Kloten/Opfiko, Zurich; Altenrhein, St. Gall)
Diaminopyrimidine:TMT
Min-max WWTPE:TMT=68-81
SPE-HPLC-(QqQ)MS/MS
na TMT=3-7
Macrolides:AZT; CTR; ERT; RXT
AZT=85-255; CTR=220-329; ERT=55-75; RXT=10-23 na AZT=1.6-2.6; CTR=1.3-3.1; ERT=3.4-9.5; RXT=0.4-1.4
Sulfonamides:SDZ; SMX; SMZ; SPD; STA
SDZ=<LOQ; SMX=352; SMZ=<LOQ-19; SPD=85-86; STA=<LOQ na SDZ=5-11; SMX=6-15; SMZ=4-17; SPD=6-19; STA=10-22
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Switzerland(Coutu et al. 2013)
WWTPI (Vidy, Lausanne)
Diaminopyrimidine:TMT
Min-max WWTPE:TMT=6.8-169
SPE-LC-MS/MS TMT=1.3 TMT=4
Lincosamide:CDM
CDM=nd-23.5 CDM=1.1 CDM=3.3
Nitroimidazole:MND
MND=nd-3,809.8 MND=1 MND=3
Quinolones:FluoroquinolonesCPF; NOF; OFX
CPF=97.65-4,186.1; NOF=<LOQ-1,283.8; OFX=10.9-1,865.3 CPF=1.2; NOF=1.3; OFX=1.2
CPF=3.5; NOF=4; OFX=3.5
(Huntscha et al. 2012)
GW (Thur River) Macrolide:CTR
Min-max GW:CTR=nd-3.7
SPE-HPLC-(QqQ)MS/MS
na CTR=0.2
Sulfonamides:SMX; SMZ
SMX=8.8-15; SMZ=5.2-6.1 na SMX=7.0; SMZ=0.2
(McArdell et al. 2003)
WWTPE (Zurich-Werdhoelzli; Kloten-Opfikon; Debendorf)
Macrolides:CTR; ERT; RXT; SPR; TLS
Min-max WWTPE:CTR=57-194; ERT=<LOQ-199; RXT=<LOQ-31; SPR=nd; TLS=nd
SPE-HPLC-(Q)MS na CTR=10; ERT=20; RXT=5; SPR=70; TLS=25
(Golet et al. 2002)
WWTPI; WWTPE (Fällanden; Kloten-Opfikon; Niederglatt; Bulach); RW (Glatt River)
Quinolones:FluoroquinolonesCPF; DIF; DNF; ERF; FRX; LMF; NOF; OFX/LVF; PPA
Min-max WWTPI:CPF=313-568; DIF=nd; DNF=nd; ERF=nd; FRX=nd; LMF=nd; NOF=255-553; OFX/LVF=nd; PPA=nd
WWTPE:CPF=62-106; DIF=nd; DNF=nd; ERF=nd; FRX=nd; LMF=nd; NOF=36-73; OFX/LVF=nd; PPA=nd
RW:CPF=5-18; DIF=nd; DNF=nd; ERF=nd; FRX=nd; LMF=nd; NOF=5-18; OFX/LVF=nd; PPA=nd
SPE-HPLC-FL CPF=2.5; DIF=2.5; DNF=0.5; ERF=3.0; FRX=2.5; LMF=3.0; NOF=2.5; OFX/LVF=5.0; PPA=3.0
CPF=9; DIF=9; DNF=5; ERF=10; FRX=9; LMF=10; NOF=9; OFX/LVF=17; PPA=10
UK(Miller et al. 2015)
RW (Thames River) Diaminopyrimidine:TMT
Min-max RW:TMT=nd-289
SPE-LC-(QqQ)MS/MS
TMT=2 TMT=5
Sulfonamides:SMZ; SPN
SMZ, SPN=nd SMZ=4; SPN=11 SMZ=15; SPN=36
(Gardner et al. 2012)
WWTPE (162 different locations)
Macrolide:ERT
Min-max WWTPE:ERT=nd-8,000
SPE-LC-MS/MS ERT=10 na
Quinolone:FluoroquinoloneOFX
OFX=nd-300 OFX=10 na
Tetracycline:OXT
OXT=nd-3,000 OXT=10 na
(Hordern et al. 2009)
WWTPI; WWTPE (Cilfynydd; Coslech); RW (Ely and Taff Rivers)
Amphenicol:CRP
Min-max WWTPI:CRP=<LOQ-452
WWTPE:CRP=<LOQ-69
RW:CRP=<LOQ-40
SPE-UPLC-(QqQ)MS/MS
CRP=0.5 CRP=2-6
Diaminopyrimidine:TMT
TMT=464-6,796 TMT=385-3,052 TMT=<LOQ-183 TMT=0.5 TMT=1.5-3
Macrolides:ERT
ERT=144-10,025 ERT=23-2,841 ERT=<LOQ-121 ERT=0.1 ERT=0.5-15
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
Nitroimidazole:MND
MND=158-1,583 MND=60-561 MND=<LOQ-24 MND=0.5 MND=1.5-16
Sulfonamide:SMX
SMX=<LOQ-274 SMX=<LOQ-44 SMX=<LOQ-8 SMX=0.1 SMX=0.5-3
(Hordern et al. 2008a)
WWTPI; WWTPE (Cilfynydd); RW (Taff Rivers)
Amphenicol:CRP
Min-max WWTPI:CRP=<LOQ
WWTPE:CRP=<LOQ
RW:CRP=<LOQ
SPE-UPLC-(QqQ)MS/MS
CRP=0.5 CRP=2-6
β-lactam: PenicillinAMX
AMX =<LOQ AMX =<LOQ AMX =<LOQ AMX =2.5 AMX =10-87
Diaminopyrimidine:TMT
TMT=1,879 TMT=1,004 TMT=<LOQ-108 TMT=0.5 TMT=1.5-3
Macrolides:ERT
ERT=404 ERT=830 ERT=<LOQ-40 ERT=0.1 ERT=0.5-15
Nitroimidazole:MND
MND=2,608 MND=373 MND=<LOQ-5 MND=0.5 MND=1.5-16
Sulfonamide:SMX
SMX=<LOQ SMX=12 SMX=<LOQ-1 SMX=0.1 SMX=0.5-3
(Hordern et al. 2008b)
RW (Taff River) Amphenicol:CRP
RW:CRP=<LOQ
SPE-UPLC-(QqQ)MS/MS
CRP=0.5 CRP=2.0
Sulfonamide:SMX
SMX=<LOQ SMX=0.5 SMX=2.0
(Hordern et al. 2008c)
RW (Ely and Taff Rivers)
Amphenicol:CRP
Min-max RW:CRP=<LOQ-40
SPE-UPLC-(QqQ)MS/MS
CRP=0.5 CRP=2
β-lactam: PenicillinAMX
AMX =<LOQ-552 AMX =2.5 AMX =10
Diaminopyrimidine:TMT
TMT=<LOQ-183 TMT=0.5 TMT=1.5
Macrolides:ERT
ERT=<LOQ-351 ERT=0.1 ERT=0.5
Nitroimidazole:MND
MND=<LOQ-24 MND=0.5 MND=1.5
Sulfonamide:SMX
SMX=<LOQ-4 SMX=0.1 SMX=0.5
(Nebot et al. 2007)
WWTPE; RW; TW; SeaW (North Scotland)
Diaminopyrimidine:TMT
WWTPE:TMT=362
RW:TMT=nd
TW:TMT=nd
SeaW:TMT=nd
SPE-HPLC-MS/MS TMT=0.07 TMT=0.25
Macrolides:ERT
ERT=186 ERT=nd ERT=nd ERT=nd ERT=0.07 ERT=0.22
Sulfonamide:SMX
SMX=nd SMX=nd SMX=nd SMX=nd SMX=0.13 SMX=0.43
(Zhang and Zhou 2007)
RW (Ouse River) Sulfonamides:SMX
Min-max RW:SMX=<LOQ-20.6
SPE-LC-(QqQ)MS/MS
SMX=0.084 SMX=0.079
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
(Roberts and Thomas 2006)
WWTPI; WWTPE (Howdon); RW (Tyne River)
Diaminopyrimidine:TMT
Min-max WWTPI:TMT=213-300
WWTPE:TMT=218-322
RW:TMT=4-19
SPE-HPLC-MS/MS TMT=10 na
Macrolides:ERT
ERT=71-141 ERT=145-290 ERT=nd-70 ERT=4 na
Sulfonamide:SMX
SMX=<LOQ SMX=<LOQ SMX=nd SMX=20 na
(Blackwell et al. 2004)
RW (Trent River, Shardlow)
Macrolides:TLS
RW:TLS=nd
SPE-HPLC-UV/Vis TLS=350 na
Sulfonamide:SCP
SCP=613,200 SCP=250 na
Tetracycline:OXT
OXT=36,100 OXT=350 na
(Thomas and Hilton 2004)
RW (Tyne, Tees, Mersey, Thames, and Belfast Lough Rivers)
Diaminopyrimidine:TMT
Min-max RW:TMT=nd-569
SPE-HPLC-MS/MS TMT=10 na
Macrolides:ERT
ERT=nd ERT=4 na
Sulfonamide:SMX
SMX=nd SMX=20 na
(Hilton and Thomas 2003)
WWTPE; SW (16 different locations)
Diaminopyrimidine:TMT
Min-max WWTPE:TMT=83-140
SW:TMT=nd-39
SPE-HPLC-MS/MS TMT=10 na
Macrolides:ERT
ERT=130-180 ERT=57-1,000 ERT=10 na
Sulfonamide:SMX
SMX=nd SMX=nd SMX=50 na
Various countries(A)
(Ruff et al. 2015)
RW (Rhine River) Diaminopyrimidine:TMT
RW:TMT=nd-25
SPE-LC-(Q-LIT-ORBITRAP)MS/MS
na TMT=1
Macrolides:AZT; CTR; ERT; TLS
AZT=nd-2; CTR=2-21; ERT=nd-13; TLS=nd na AZT=1; CTR=1; ERT=10; TLS=50
Nitroimidazole:MND
MND=nd na MND=5
Quinolones:FluoroquinolonesCPF; NOF; RXT
CPF=nd; NOF=nd; RXT=nd-8 na CPF=100; NOF=100; RXT=5
Sulfonamides:SDM; SDZ; SMX; SMZ; SPD; STA
SDM=nd; SDZ=nd; SMX=3-47; SMZ=nd; SPD=nd-9; STA=nd-101 na SDM=5; SDZ=10; SMX=1; SMZ=10; SPD=5; STA=10
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
(B)(Loos et al. 2013)
WWTPE Amphenicol:FFN
Max WWTPE:FFN=nd
SPE-LC-(QqQ)MS/MS
na FFN=100
β-lactams: PenicillinsAMX; PNG; PNV
AMP=nd; AMX=nd; PNG=nd; PNV=33 na AMP=25; AMX=25; PNG=50; PNV=50
Diaminopyrimidine:TMT
TMT=800 na TMT=10
Lincosamides:CDM; LCM
CDM=277; LCM=317 na CDM=10; LCM=15
Macrolides:TLS; TMC
TLS=nd; TMC=93.2 na TLS=50; TMC=20
Pleuromutilin:TAM
TAM=44.5 na TAM=20
Quinolones:FluoroquinolonesCPF; ERFOther quinolonesFMQ
CPF=264; ERF=nd; FMQ=25.7 na CPF=15; ERF=20; FMQ=20
Sulfonamides:SDX; SDZ; SMX
SDX=nd; SDZ=105; SMX=1,691 na SDX=20; SDZ=30; SMX=50
Tetracyclines:DXC; OXT
DXC, OXT=nd na DXC=50; OXT=30
(C)(Loos, Locoro, Comero, et al. 2010)
GW Sulfonamide:SMX
Max GW:SMX=38
SPE-LC-(QqQ)MS/MS
SMX=0.5 na
(D)(Loos, Locoro, and Contini 2010)
RW (Danube River and tributaries)
Sulfonamide:SMX
Max RW:SMX=28-204
SPE-LC-(QqQ)MS/MS
SMX=1 na
(E)(Terzić et al. 2008)
WWTPI Diaminopyrimidine:TMT
Min-max WWTPI:TMT=nd-2,550
SPE-LC-(QqQ)MS/MS
TMT=12 na
Macrolides:AZT; ERT; JSM; RXT
AZT=nd-1,140; ERT=nd-420; JSM=nd-16; RXT=nd-50 AZT=2; ERT=1; JSM=8; RXT=2
na
Quinolones:FluoroquinolonesCPF; ERF; NOF; OFX
CPF=nd-2,610; ERF=nd-18; NOF=nd-2,940; OFX=nd-<LOQ CPF=7; ERF=2; NOF=3; OFX=42
na
Sulfonamides:SDZ; SMR; SMX; SMZ; SPD; STA
SDZ=nd-132; SMR=nd-20; SMX=nd-11,600; SMZ=nd-186; SPD=nd-931; STA=nd-4
SDZ=1; SMR=1; SMX=1; SMZ=2; SPD=4; STA=1
na
Table S1. (Continuation).Study (Reference)
Matrices (location)
Antibiotic classes:Active agents
Concentrations (ng L-1) Analytical methods
Analytical parameters (ng L-1)LOD LOQ
(F)(Hordern et al. 2007)
RW (Taff River and Warta Rivers)
Amphenicol:CRP
Min-max RW:CRP=<LOQ
SPE-UPLC-(QqQ)MS/MS
CRP=2.5 na
β-lactam:Penicillin AMX
AMX=<LOQ-245 AMX=2.5 na
Diaminopyrimidine:TMT
TMT=<LOQ-27 TMT=0.5 na
Macrolide:ERT
ERT=<LOQ-22 ERT=0.1 na
Nitroimidazole:MND
MND=<LOQ MND=0.5 na
Quinolone:FluoroquinoloneCPF
CPF=nr CPF=nr na
Sulfonamides:SMX; SPD
SMX=<LOQ-39; SPD=<LOQ-60 SMX=0.5; SPD=0.1
na
Tetracyclines:DXC
DXC=nr DXC=nr na
(G)(Petrovic et al. 2006)
WWTPI; WWTPE Diaminopyrimidine:TMT
Min-max WWTPI:TMT=40-650
WWTPE:TMT=nd-230
SPE-UPLC-(Q-TOF)MS/MS
TMT=10 na
Macrolides:AZT; ERT
AZT=nd-450; ERT=nd-250 AZT=nd-300; ERT=nd-280 AZT=70; ERT=100 na
Quinolone:FluoroquinoloneOFX
OFX=nd OFX=nd OFX=500 na
Sulfonamide:SMX
SMX=nd-960 SMX=nd-800 SMX=150 na
AbbreviationsStudy: Various countries: (A) - Germany and Netherlands border; (B) - Austria, Belgium, Cyprus, Czech Republic, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Lithuania, Netherlands,
Portugal, Slovenia, Spain, Sweden, and Switzerland; (C) - Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Luxembourg, Netherlands, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, UK; (D) - Austria, Bulgaria, Czech Republic, Denmark, Germany, Hungary, Romania, Serbia, and Slovakia; E - Bosnia and Herzegovina, Croatia, and Serbia; (F) - Poland and UK; (G) - Croatia and Spain.
Matrices: DW - drinking water; DWWTPE - domestic wastewater treatment plant effluent; GW - groundwater; HWWTPE - hospital wastewater treatment plant effluent; HWWTPI - hospital wastewater treatment plant influent; LW - lake water; ResW - reservoir water; RW - river water; SeaW - sea water; SW - surface water; TW - tap water; WLW - wetland water; WTPE - water treatment plant effluent; WW - wastewater; WWTPE - wastewater treatment plant effluent; WWTPI - wastewater treatment plant influent.
Active agents: aminoglycoside: streptomycins: DST - dihydrostreptomycin, STM - streptomycin; other aminoglycosides: NMC - neomycin; amphenicols: CRP - chloramphenicol, FFN - florfenicol, TAP - thiamphenicol; β-lactams: cephalosporins: CDX - cefadroxil, CLX - cefalexin, CPD - cefpodoxime, CPR - cefapirin, CPZ - cefoperazone, CQN - cefquinome, CRX - cefuroxime, CTF - ceftiofur, CTN - ceftriaxone, CTX - cefotaxime, CTZ – ceftazidime, CZL - cefazolin; penicillins: AMP - ampicillin, AMX - amoxicillin, BZP - benzylpenicillin, CXC - cloxacillin, DCX - dicloxacillin, FCX - flucloxacillin, MTC - meticillin, MZC - mezlocillin, NFC - nafcillin, OXC - oxacillin, PNG - penicillin G, PNV - penicillin V, PNX - phenoxymethylpenicillin, PPR – piperacillin; diaminopyrimidines: TMT - trimethoprim, OMT - ormethoprim; glycopeptides: VCM - vancomycin; lincosamides: CDM - clindamycin, LCM - lincomycin; macrolides: AZT - azithromycin, CTR - clarithromycin, ERT - erythromycin, JSM - josamycin, OLD - oleandomycin, RXT - roxithromycin, SPR - spiramycin, TLS - tylosin, TMC - tilmicosin; nitroimidazoles: DTZ - dimetridazole, MND - metronidazole, OND - ornidazole, RND - ronidazole; pleuromutilins: TAM - tiamulin, VNM - valnemulin; quinolones: fluoroquinolones: BSF - besifloxacin, CPF - ciprofloxacin, DIF - difloxacin, DNF - danofloxacin, ENX - enoxacin, ERF - enrofloxacin, FRX - fleroxacin, GTF - gatifloxacin, LMF - lomefloxacin, LVF - levofloxacin, MBF - marbofloxacin, MXF - moxifloxacin, NOF - norfloxacin, OBF - orbifloxacin, OFX - ofloxacin, PEF -
pefloxacin, SRF - sarafloxacin; other quinolones: CNO - cinoxacin, FMQ - flumequine, NLA - nalidixic acid, OXA - oxolinic acid, PPA - pipemidic acid; steroid antibacterials: FSA - fusidic acid; streptogramin: VGN - virginiamycin; sulfonamides: SBZ - sulfabenzamide, SCP - sulfachlorpyridazine, SCT - sulfacetamide, SCZ - sulfachloropyrazine, SDD - sulfadimidine, SDM - sulfadimethoxine, SDX - sulfadoxine, SDZ - sulfadiazine, SGD - sulfaguanidine, SMM - sulfamonomethoxine, SMP - sulfamethoxypyridazine, SMR - sulfamerazine, SMT - sulfamethizole, SMX - sulfamethoxazole, SMZ - sulfamethazine, SNL - sulfanilamide, SNT - sulfanitran, SPD - sulfapyridine, SPN - sulfaphenazole, SQN - sulfaquinoxaline, SSD - sulfisomidine, SSL - sulfasalazine, SSX - sulfisoxazole, STA - sulfathiazole, STZ - sulfamethiazole, SXL - sulfamoxole; tetracyclines: CTC - chlortetracycline, DMC - demeclocycline, DXC - doxycycline, OXT - oxytetracycline, TTC - tetracycline; other antibacterials: MNN - monensine, SLN - salinomycin, SPT - spectinomycin.
Concentrations: max - maximum detected value; min – minimum detected value; nd - not detected; nr - not recovered; nq - not quantified.Analytical methods: sample preparation methods: DLLME - dispersive liquid-liquid microextraction, SPE - solid phase extraction; SPME - solid-phase microextraction; chromatography
separation methods: HPLC - high performance liquid chromatography; HRMS - high resolution mass spectrometry, LC - liquid chromatography, RRLC - rapid resolution liquid chromatography, UHPLC - ultra high performance liquid chromatography, UPLC - ultra-performance liquid chromatography; detection methods: DAD - diode array detector, FL - fluorescence detector, MS - mass spectrometry (IT - ion trap; LIT - linear ion trap; HRMS - high resolution mass spectrometry; Q - single quadrupole; QqQ - triple quadrupole; TOF - time of fligh; UIT - ultra ion trap), UV/Vis - ultraviolet/visible.
Analytical parameters: LOD - limit of detection; LOQ - limit of quantification; na - information not available.
ReferencesAl Aukidy, M., Verlicchi, P., Jelic, A., Petrovic, M., & Barcelò, D. (2012). Monitoring release of pharmaceutical
compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies
in the Po Valley, Italy. The Science of the Total Environment, 438, 15–25. doi:10.1016/j.scitotenv.2012.08.061
Alygizakis, N. A., Ferrero, P. G., Borova, V. L., Pavlidou, A., Hatzianestis, I., & Thomaidis, N. S. (2016).
Occurrence and spatial distribution of 158 pharmaceuticals, drugs of abuse and related metabolites in offshore
seawater. The Science of the Total Environment, 541, 1097–105. doi:10.1016/j.scitotenv.2015.09.145
Andreozzi, R., Caprio, V., Ciniglia, C., Champdoré, M., Lo Giudice, R., Marotta, R., & Zuccato, E. (2004).
Antibiotics in the environment: Occurrence in Italian STPs, fate, and preliminary assessment on algal toxicity
of amoxicillin. Environmental Science & Technology, 38(24), 6832–6838. doi:10.1021/es049509a
Andreozzi, R., Raffaele, M., & Nicklas, P. (2003). Pharmaceuticals in STP effluents and their solar photodegradation
in aquatic environment. Chemosphere, 50(10), 1319–1330. doi:10.1016/S0045-6535(02)00769-5
Babić, S., Asperger, D., Mutavdzić, D., Horvat, A. J. M., & Macan, M. K. (2006). Solid phase extraction and HPLC
determination of veterinary pharmaceuticals in wastewater. Talanta, 70(4), 732–738.
doi:10.1016/j.talanta.2006.07.003
Baumann, M., Weiss, K., Maletzki, D., Schüssler, W., Schudoma, D., Kopf, W., & Kühnen, U. (2015). Aquatic
toxicity of the macrolide antibiotic clarithromycin and its metabolites. Chemosphere, 120, 192–198.
doi:10.1016/j.chemosphere.2014.05.089
Bendz, D., Paxéus, N. A., Ginn, T. R., & Loge, F. J. (2005). Occurrence and fate of pharmaceutically active
compounds in the environment, a case study: Höje River in Sweden. Journal of Hazardous Materials, 122(3),
195–204. doi:10.1016/j.jhazmat.2005.03.012
Birošová, L., Mackulak, T., Bodík, I., Ryba, J., Škubák, J., & Grabic, R. (2014). Pilot study of seasonal occurrence
and distribution of antibiotics and drug resistant bacteria in wastewater treatment plants in Slovakia. The
Science of the Total Environment, 490, 440–444. doi:10.1016/j.scitotenv.2014.05.030
Blackwell, P. A., Lützhøft, H. C. H., Ma, H. P., Sørensen, B. H., Boxall, A. B. A., & Kay, P. (2004). Fast and robust
simultaneous determination of three veterinary antibiotics in groundwater and surface water using a tandem
solid-phase extraction with high-performance liquid chromatography–UV detection. Journal of
Chromatography A, 1045(1-2), 111–117. doi:10.1016/j.chroma.2004.05.063
Boix, C., Ibáñez, M., Sancho, J. V., Rambla, J., Aranda, J. L., Ballester, S., & Hernández, F. (2015). Fast
determination of 40 drugs in water using large volume direct injection liquid chromatography-tandem mass
spectrometry. Talanta, 131, 719–727. doi:10.1016/j.talanta.2014.08.005
Boleda, M. R., Galceran, M. T., & Ventura, F. (2013). Validation and uncertainty estimation of a multiresidue
method for pharmaceuticals in surface and treated waters by liquid chromatography-tandem mass
spectrometry. Journal of Chromatography A, 1286, 146–158. doi:10.1016/j.chroma.2013.02.077
Borecka, M., Bielińska, A. B., Siedlewicz, G., Kornowska, K., Kumirska, J., Stepnowski, P., & Pazdro, K. (2013). A
new approach for the estimation of expanded uncertainty of results of an analytical method developed for
determining antibiotics in seawater using solid-phase extraction disks and liquid chromatography coupled with
tandem mass spectrometry technique. Journal of Chromatography A, 1304, 138–146.
doi:10.1016/j.chroma.2013.07.018
Cabeza, Y., Candela, L., Ronen, D., & Teijon, G. (2012). Monitoring the occurrence of emerging contaminants in
treated wastewater and groundwater between 2008 and 2010. The Baix Llobregat (Barcelona, Spain). Journal
of Hazardous Materials, 239-240, 32–39. doi:10.1016/j.jhazmat.2012.07.032
Castiglioni, S., Bagnati, R., Calamari, D., Fanelli, R., & Zuccato, E. (2005). A multiresidue analytical method using
solid-phase extraction and high-pressure liquid chromatography tandem mass spectrometry to measure
pharmaceuticals of different therapeutic classes in urban wastewaters. Journal of Chromatography A, 1092(2),
206–215. doi:10.1016/j.chroma.2005.07.012
Celano, R., Piccinelli, A. L., Campone, L., & Rastrelli, L. (2014). Ultra-preconcentration and determination of
selected pharmaceutical and personal care products in different water matrices by solid-phase extraction
combined with dispersive liquid-liquid microextraction prior to ultra high pressure liquid chromatography.
Journal of Chromatography A, 1355, 26–35. doi:10.1016/j.chroma.2014.06.009
Chitescu, C. L., Kaklamanos, G., Nicolau, A. I., & Stolker, A. A. M. L. (2015). High sensitive multiresidue analysis
of pharmaceuticals and antifungals in surface water using U-HPLC-Q-Exactive Orbitrap HRMS. Application
to the Danube river basin on the Romanian territory. The Science of the Total Environment, 532, 501–511.
doi:10.1016/j.scitotenv.2015.06.010
Chițescu, C. L., & Nicolau, A. I. (2014). Preliminary survey of pharmaceutical residues in some important Romanian
rivers. Toxicological & Environmental Chemistry, 96(9), 1333–1345. doi:10.1080/02772248.2015.1005092
Chitescu, C. L., Oosterink, E., Jong, J., & Stolker, A. A. M. L. (2012). Accurate mass screening of pharmaceuticals
and fungicides in water by U-HPLC-Exactive Orbitrap MS. Analytical and bioanalytical chemistry, 403(10),
2997–3011. doi:10.1007/s00216-012-5888-8
Christian, T., Schneider, R. J., Färber, H. A., Skutlarek, D., Meyer, M. T., & Goldbach, H. E. (2003). Determination
of Antibiotic Residues in Manure, Soil, and Surface Waters. Acta Hydrochimica et Hydrobiologica, 31(1), 36–
44. doi:10.1002/aheh.200390014
Clara, M., Strenn, B., Gans, O., Martinez, E., Kreuzinger, N., & Kroiss, H. (2005). Removal of selected
pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional
wastewater treatment plants. Water research, 39(19), 4797–4807. doi:10.1016/j.watres.2005.09.015
Climent, L. F., Mozaz, S. R., & Barceló, D. (2014). Incidence of anticancer drugs in an aquatic urban system: from
hospital effluents through urban wastewater to natural environment. Environmental Pollution, 193, 216–223.
doi:10.1016/j.envpol.2014.07.002
Collado, N., Mozaz, S. R., Gros, M., Rubirola, A., Barceló, D., Comas, J., et al. (2014). Pharmaceuticals occurrence
in a WWTP with significant industrial contribution and its input into the river system. Environmental
Pollution, 185, 202–212. doi:10.1016/j.envpol.2013.10.040
Coutu, S., Wyrsch, V., Wynn, H. K., Rossi, L., & Barry, D. A. (2013). Temporal dynamics of antibiotics in
wastewater treatment plant influent. The Science of the Total Environment, 458-460, 20–26.
doi:10.1016/j.scitotenv.2013.04.017
Cruz, M. S. D., Galán, M. J. G., & Barceló, D. (2008). Highly sensitive simultaneous determination of sulfonamide
antibiotics and one metabolite in environmental waters by liquid chromatography–quadrupole linear ion trap–
mass spectrometry. Journal of Chromatography A, 1193(1-2), 50–59. doi:10.1016/j.chroma.2008.03.029
Dévier, M. H., Le Menach, K., Viglino, L., Di Gioia, L., Lachassagne, P., & Budzinski, H. (2013). Ultra-trace
analysis of hormones, pharmaceutical substances, alkylphenols and phthalates in two French natural mineral
waters. The Science of the Total Environment, 443, 621–632. doi:10.1016/j.scitotenv.2012.10.015
Dinh, Q. T., Alliot, F., Guigon, E. M., Eurin, J., Chevreuil, M., & Labadie, P. (2011). Measurement of trace levels of
antibiotics in river water using on-line enrichment and triple-quadrupole LC-MS/MS. Talanta, 85(3), 1238–
1245. doi:10.1016/j.talanta.2011.05.013
Felizzola, J. F., & Chiron, S. (2009). Occurrence and distribution of selected antibiotics in a small Mediterranean
stream (Arc River, Southern France). Journal of Hydrology, 364(1-2), 50–57.
doi:10.1016/j.jhydrol.2008.10.006
Gaffney, V. J., Almeida, C. M. M., Rodrigues, A., Ferreira, E., Benoliel, M. J., & Cardoso, V. V. (2015). Occurrence
of pharmaceuticals in a water supply system and related human health risk assessment. Water Research, 72,
199–208. doi:10.1016/j.watres.2014.10.027
Galán, M. J. G., Blanco, S. G., Roldán, R. L., Cruz, S. D., & Barceló, D. (2012). Ecotoxicity evaluation and removal
of sulfonamides and their acetylated metabolites during conventional wastewater treatment. The Science of the
Total Environment, 437, 403–412. doi:10.1016/j.scitotenv.2012.08.038
Galán, M. J. G., Cruz, M. S. D., & Barceló, D. (2010). Determination of 19 sulfonamides in environmental water
samples by automated on-line solid-phase extraction-liquid chromatography-tandem mass spectrometry (SPE-
LC-MS/MS). Talanta, 81(1-2), 355–366. doi:10.1016/j.talanta.2009.12.009
Galán, M. J. G., Cruz, M. S. D., & Barceló, D. (2011). Occurrence of sulfonamide residues along the Ebro River
basin: removal in wastewater treatment plants and environmental impact assessment. Environment
International, 37(2), 462–473. doi:10.1016/j.envint.2010.11.011
Galán, M. J. G., Garrido, T., Fraile, J., Ginebreda, A., Cruz, M. S. D., & Barceló, D. (2010). Simultaneous occurrence
of nitrates and sulfonamide antibiotics in two ground water bodies of Catalonia (Spain). Journal of Hydrology,
383(1-2), 93–101. doi:10.1016/j.jhydrol.2009.06.042
Galán, M. J. G., Villagrasa, M., Cruz, M. S. D., & Barceló, D. (2010). LC-QqLIT MS analysis of nine sulfonamides
and one of their acetylated metabolites in the Llobregat River basin. Quantitative determination and qualitative
evaluation by IDA experiments. Analytical and Bioanalytical Chemistry, 397(3), 1325–1334.
doi:10.1007/s00216-010-3630-y
Gardner, M., Comber, S., Scrimshaw, M. D., Cartmell, E., Lester, J., & Ellor, B. (2012). The significance of
hazardous chemicals in wastewater treatment works effluents. Science of The Total Environment, 437, 363–
372. doi:10.1016/j.scitotenv.2012.07.086
Göbel, A., McArdell, C. S., Suter, M. J. F., & Giger, W. (2004). Trace determination of macrolide and sulfonamide
antimicrobials, a human sulfonamide metabolite, and trimethoprim in wastewater using liquid chromatography
coupled to electrospray tandem mass spectrometry. Analytical Chemistry, 76(16), 4756–4764.
doi:10.1021/ac0496603
Golet, E. M., Alder, A. C., & Giger, W. (2002). Environmental exposure and risk assessment of fluoroquinolone
antibacterial agents in wastewater and river water of the Glatt Valley Watershed, Switzerland. Environmental
Science & Technology, 36(17), 3645–3651. doi:10.1021/es0256212
Golovko, O., Kumar, V., Fedorova, G., Randak, T., & Grabic, R. (2014). Seasonal changes in antibiotics,
antidepressants/psychiatric drugs, antihistamines and lipid regulators in a wastewater treatment plant.
Chemosphere, 111, 418–426. doi:10.1016/j.chemosphere.2014.03.132
Gómez, M. J., Petrović, M., Alba, A. R. F., & Barceló, D. (2006). Determination of pharmaceuticals of various
therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in
hospital effluent wastewaters. Journal of Chromatography A, 1114(2), 224–233.
doi:10.1016/j.chroma.2006.02.038
González, R. M., Mozaz, S. R., Gros, M., Barceló, D., & León, V. M. (2015). Seasonal distribution of
pharmaceuticals in marine water and sediment from a Mediterranean coastal lagoon (SE Spain).
Environmental Research, 138, 326–344. doi:10.1016/j.envres.2015.02.016
González, R. M., Mozaz, S. R., Gros, M., Cánovas, E. P., Barceló, D., & León, V. M. (2014). Input of
pharmaceuticals through coastal surface watercourses into a Mediterranean Lagoon (Mar Menor, SE Spain):
Sources and seasonal variations. The Science of the Total Environment, 490, 59–72.
doi:10.1016/j.scitotenv.2014.04.097
Grabic, R., Fick, J., Lindberg, R. H., Fedorova, G., & Tysklind, M. (2012). Multi-residue method for trace level
determination of pharmaceuticals in environmental samples using liquid chromatography coupled to triple
quadrupole mass spectrometry. Talanta, 100, 183–195. doi:10.1016/j.talanta.2012.08.032
Gros, M., Mozaz, S. R., & Barceló, D. (2012). Fast and comprehensive multi-residue analysis of a broad range of
human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-
high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem. Journal of
Chromatography A, 1248, 104–121. doi:10.1016/j.chroma.2012.05.084
Gros, M., Mozaz, S. R., & Barceló, D. (2013). Rapid analysis of multiclass antibiotic residues and some of their
metabolites in hospital, urban wastewater and river water by ultra-high performance liquid chromatography
coupled to quadrupole-linear ion trap tandem mass spectrometry. Journal of Chromatography A, 1292, 173–
188. doi:10.1016/j.chroma.2012.12.072
Gros, M., Petrović, M., & Barceló, D. (2006). Development of a multi-residue analytical methodology based on
liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of
pharmaceuticals in surface and wastewaters. Talanta, 70(4), 678–690. doi:10.1016/j.talanta.2006.05.024
Gros, M., Petrović, M., & Barceló, D. (2007). Wastewater treatment plants as a pathway for aquatic contamination by
pharmaceuticals in the Ebro River Basin (Northeast Spain). Environmental Toxicology and Chemistry, 26(8),
1553–1562. doi:10.1897/06-495R.1
Hilton, M. J., & Thomas, K. V. (2003). Determination of selected human pharmaceutical compounds in effluent and
surface water samples by high-performance liquid chromatography–electrospray tandem mass spectrometry.
Journal of Chromatography A, 1015(1-2), 129–141. doi:10.1016/S0021-9673(03)01213-5
Hordern, B. K., Dinsdale, R. M., & Guwy, A. J. (2007). Multiresidue method for the determination of basic/neutral
pharmaceuticals and illicit drugs in surface water by solid-phase extraction and ultra performance liquid
chromatography-positive electrospray ionisation tandem mass spectrometry. Journal of Chromatography A,
1161(1-2), 132–145. doi:10.1016/j.chroma.2007.05.074
Hordern, B. K., Dinsdale, R. M., & Guwy, A. J. (2008a). Multiresidue methods for the analysis of pharmaceuticals,
personal care products and illicit drugs in surface water and wastewater by solid-phase extraction and ultra
performance liquid chromatography-electrospray tandem mass spectrometry. Analytical and Bioanalytical
Chemistry, 391, 1293–1308. doi:10.1007/s00216-008-1854-x
Hordern, B. K., Dinsdale, R. M., & Guwy, A. J. (2008b). The effect of signal suppression and mobile phase
composition on the simultaneous analysis of multiple classes of acidic/neutral pharmaceuticals and personal
care products in surface water by solid-phase extraction and ultra performance liquid chromatogra. Talanta,
74(5), 1299–1312. doi:10.1016/j.talanta.2007.08.037
Hordern, B. K., Dinsdale, R. M., & Guwy, A. J. (2008c). The occurrence of pharmaceuticals, personal care products,
endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Research, 42(13), 3498–
3518. doi:10.1016/j.watres.2008.04.026
Hordern, B. K., Dinsdale, R. M., & Guwy, A. J. (2009). The removal of pharmaceuticals, personal care products,
endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving
waters. Water Research, 43(2), 363–380. doi:10.1016/j.watres.2008.10.047
Huntscha, S., Singer, H. P., McArdell, C. S., Frank, C. E., & Hollender, J. (2012). Multiresidue analysis of 88 polar
organic micropollutants in ground, surface and wastewater using online mixed-bed multilayer solid-phase
extraction coupled to high performance liquid chromatography–tandem mass spectrometry. Journal of
Chromatography A, 1268, 74–83. doi:10.1016/j.chroma.2012.10.032
Iglesias, A., Nebot, C., Miranda, J. M., Vázquez, B. I., Abuín, C. M. F., & Cepeda, A. (2013). Determination of the
presence of three antimicrobials in surface water collected from urban and rural areas. Antibiotics, 2(1), 46–57.
doi:10.3390/antibiotics2010046
Jeanton, H. C., Schemberg, D., Mohammed, N., Huneau, F., Bertrand, G., Lavastre, V., & Le Coustumer, P. (2014).
Evaluation of pharmaceuticals in surface water: reliability of PECs compared to MECs. Environment
International, 73, 10–21. doi:10.1016/j.envint.2014.06.015
Jongh, C. M., Kooij, P. J. F., Voogt, P., & Laak, T. L. (2012). Screening and human health risk assessment of
pharmaceuticals and their transformation products in Dutch surface waters and drinking water. The Science of
the Total Environment, 427-428, 70–77. doi:10.1016/j.scitotenv.2012.04.010
Joss, A., Keller, E., Alder, A. C., Göbel, A., McArdell, C. S., Ternes, T., & Siegrist, H. (2005). Removal of
pharmaceuticals and fragrances in biological wastewater treatment. Water Research, 39(14), 3139–3152.
doi:10.1016/j.watres.2005.05.031
Kosma, C. I., Lambropoulou, D. A., & Albanis, T. A. (2014). Investigation of PPCPs in wastewater treatment plants
in Greece: occurrence, removal and environmental risk assessment. The Science of the Total Environment,
466-467, 421–438. doi:10.1016/j.scitotenv.2013.07.044
Laak, T. L., Aa, M., Houtman, C. J., Stoks, P. G., & Wezel, A. P. (2010). Relating environmental concentrations of
pharmaceuticals to consumption: A mass balance approach for the River Rhine. Environment International,
36(5), 403–9. doi:10.1016/j.envint.2010.02.009
Lindberg, R. H., Wennberg, P., Johansson, M. I., Tysklind, M., & Andersson, B. A. V. (2005). Screening of human
antibiotic substances and determination of weekly mass flows in five sewage treatment plants in Sweden.
Environmental Science & Technology, 39(10), 3421–3429. doi:10.1021/es048143z
Lindberg, R., Jarnheimer, P. A., Olsen, B., Johansson, M., & Tysklind, M. (2004). Determination of antibiotic
substances in hospital sewage water using solid phase extraction and liquid chromatography/mass
spectrometry and group analogue internal standards. Chemosphere, 57(10), 1479–1488.
doi:10.1016/j.chemosphere.2004.09.015
Loos, R., Carvalho, R., António, D. C., Comero, S., Locoro, G., Tavazzi, S., et al. (2013). EU-wide monitoring
survey on emerging polar organic contaminants in wastewater treatment plant effluents. Water research,
47(17), 6475–6487. doi:10.1016/j.watres.2013.08.024
Loos, R., Locoro, G., Comero, S., Contini, S., Schwesig, D., Werres, F., et al. (2010). Pan-European survey on the
occurrence of selected polar organic persistent pollutants in ground water. Water Research, 44(14), 4115–
4126. doi:10.1016/j.watres.2010.05.032
Loos, R., Locoro, G., & Contini, S. (2010). Occurrence of polar organic contaminants in the dissolved water phase of
the Danube River and its major tributaries using SPE-LC-MS(2) analysis. Water Research, 44(7), 2325–2335.
doi:10.1016/j.watres.2009.12.035
Lor, E. G., Sancho, J. V., & Hernández, F. (2011). Multi-class determination of around 50 pharmaceuticals, including
26 antibiotics, in environmental and wastewater samples by ultra-high performance liquid chromatography-
tandem mass spectrometry. Journal of Chromatography A, 1218(16), 2264–2275.
doi:10.1016/j.chroma.2011.02.026
Lor, E. G., Sancho, J. V., Serrano, R., & Hernández, F. (2012). Occurrence and removal of pharmaceuticals in
wastewater treatment plants at the Spanish Mediterranean area of Valencia. Chemosphere, 87(5), 453–462.
doi:10.1016/j.chemosphere.2011.12.025
Madureira, T. V., Barreiro, J. C., Rocha, M. J., Cass, Q. B., & Tiritan, M. E. (2009). Pharmaceutical trace analysis in
aqueous environmental matrices by liquid chromatography-ion trap tandem mass spectrometry. Journal of
Chromatography A, 1216(42), 7033–7042. doi:10.1016/j.chroma.2009.08.060
Maier, D., Blaha, L., Giesy, J. P., Henneberg, A., Köhler, H. R., Kuch, B., et al. (2015). Biological plausibility as a
tool to associate analytical data for micropollutants and effect potentials in wastewater, surface water, and
sediments with effects in fishes. Water Research, 72, 127–144. doi:10.1016/j.watres.2014.08.050
McArdell, C. S., Molnar, E., Suter, M. J. F., & Giger, W. (2003). Occurrence and fate of macrolide antibiotics in
wastewater treatment plants and in the Glatt Valley Watershed, Switzerland. Environmental Science &
Technology, 37(24), 5479–5486. doi:10.1021/es034368i
McEneff, G., Barron, L., Kelleher, B., Paull, B., & Quinn, B. (2014). A year-long study of the spatial occurrence and
relative distribution of pharmaceutical residues in sewage effluent, receiving marine waters and marine
bivalves. The Science of the Total Environment, 476-477, 317–326. doi:10.1016/j.scitotenv.2013.12.123
Mendoza, A., Aceña, J., Pérez, S., Alda, M. L., Barceló, D., Gil, A., & Valcárcel, Y. (2015). Pharmaceuticals and
iodinated contrast media in a hospital wastewater: A case study to analyse their presence and characterise their
environmental risk and hazard. Environmental Research, 140, 225–41. doi:10.1016/j.envres.2015.04.003
Miller, T. H., McEneff, G. L., Brown, R. J., Owen, S. F., Bury, N. R., & Barron, L. P. (2015). Pharmaceuticals in the
freshwater invertebrate, Gammarus pulex, determined using pulverised liquid extraction, solid phase extraction
and liquid chromatography-tandem mass spectrometry. The Science of the Total Environment, 511, 153–160.
doi:10.1016/j.scitotenv.2014.12.034
Molina, J. R., López, B. G., Reyes, J. F. G., & Díaz, A. M. (2014). Monitoring of selected priority and emerging
contaminants in the Guadalquivir River and other related surface waters in the province of Jaén, South East
Spain. The Science of the Total Environment, 479-480, 247–257. doi:10.1016/j.scitotenv.2014.01.121
Muñoz, D. C., Martín, J., Santos, J. L., Aparicio, I., & Alonso, E. (2009). An affordable method for the simultaneous
determination of the most studied pharmaceutical compounds as wastewater and surface water pollutants.
Journal of Separation Science, 32(18), 3064–3073. doi:10.1002/jssc.200900128
Muñoz, D. C., Martín, J., Santos, J. L., Aparicio, I., & Alonso, E. (2010). Occurrence, temporal evolution and risk
assessment of pharmaceutically active compounds in Doñana Park (Spain). Journal of Hazardous Materials,
183(1-3), 602–608. doi:10.1016/j.jhazmat.2010.07.067
Nebot, C., Gibb, S. W., & Boyd, K. G. (2007). Quantification of human pharmaceuticals in water samples by high
performance liquid chromatography-tandem mass spectrometry. Analytica Chimica Acta, 598(1), 87–94.
doi:10.1016/j.aca.2007.07.029
Nödler, K., Licha, T., Bester, K., & Sauter, M. (2010). Development of a multi-residue analytical method, based on
liquid chromatography-tandem mass spectrometry, for the simultaneous determination of 46 micro-
contaminants in aqueous samples. Journal of Chromatography A, 1217(42), 6511–6521.
doi:10.1016/j.chroma.2010.08.048
Opriş, O., Soran, M. L., Coman, V., Copaciu, F., & Ristoiu, D. (2013). Determination of some frequently used
antibiotics in waste waters using solid phase extraction followed by high performance liquid chromatography
with diode array and mass spectrometry detection. Central European Journal of Chemistry, 11(8), 1343–1351.
doi:10.2478/s11532-013-0263-y
Osorio, V., Larrañaga, A., Aceña, J., Pérez, S., & Barceló, D. (2015). Concentration and risk of pharmaceuticals in
freshwater systems are related to the population density and the livestock units in Iberian Rivers. The Science
of the Total Environment, 540, 267–277. doi:10.1016/j.scitotenv.2015.06.143
Osorio, V., Marcé, R., Pérez, S., Ginebreda, A., Cortina, J. L., & Barceló, D. (2012). Occurrence and modeling of
pharmaceuticals on a sewage-impacted Mediterranean River and their dynamics under different hydrological
conditions. The Science of the Total Environment, 440, 3–13. doi:10.1016/j.scitotenv.2012.08.040
Pailler, J. Y., Krein, A., Pfister, L., Hoffmann, L., & Guignard, C. (2009). Solid phase extraction coupled to liquid
chromatography-tandem mass spectrometry analysis of sulfonamides, tetracyclines, analgesics and hormones
in surface water and wastewater in Luxembourg. The Science of the Total Environment, 407(16), 4736–4743.
doi:10.1016/j.scitotenv.2009.04.042
Papageorgiou, M., Kosma, C., & Lambropoulou, D. (2016). Seasonal occurrence, removal, mass loading and
environmental risk assessment of 55 pharmaceuticals and personal care products in a municipal wastewater
treatment plant in Central Greece. The Science of the Total Environment, 543, 547–569.
doi:10.1016/j.scitotenv.2015.11.047
Pasquini, L., Munoz, J. F., Pons, M. N., Yvon, J., Dauchy, X., France, X., et al. (2014). Occurrence of eight
household micropollutants in urban wastewater and their fate in a wastewater treatment plant. Statistical
evaluation. The Science of the Total Environment, 481, 459–468. doi:10.1016/j.scitotenv.2014.02.075
Pena, A., Chmielova, D., Lino, C. M., & Solich, P. (2007). Determination of fluoroquinolone antibiotics in surface
waters from Mondego River by high performance liquid chromatography using a monolithic column. Journal
of Separation Science, 30(17), 2924–4928. doi:10.1002/jssc.200700363
Pereira, A. M. P. T., Silva, L. J. G., Meisel, L. M., Lino, C. M., & Pena, A. (2015). Environmental impact of
pharmaceuticals from Portuguese wastewaters: geographical and seasonal occurrence, removal and risk
assessment. Environmental Research, 136, 108–119. doi:10.1016/j.envres.2014.09.041
Petrovic, M., Gros, M., & Barcelo, D. (2006). Multi-residue analysis of pharmaceuticals in wastewater by ultra-
performance liquid chromatography-quadrupole-time-of-flight mass spectrometry. Journal of Chromatography
A, 1124(1-2), 68–81. doi:10.1016/j.chroma.2006.05.024
Reverté, S., Borrull, F., Pocurull, E., & Marcé, R. M. (2003). Determination of antibiotic compounds in water by
solid-phase extraction–high-performance liquid chromatography–(electrospray) mass spectrometry. Journal of
Chromatography A, 1010(2), 225–232. doi:10.1016/S0021-9673(03)01064-1
Roberts, P. H., & Thomas, K. V. (2006). The occurrence of selected pharmaceuticals in wastewater effluent and
surface waters of the lower Tyne catchment. The Science of the Total Environment, 356(1-3), 143–153.
doi:10.1016/j.scitotenv.2005.04.031
Roig, P. V., Andreu, V., Blasco, C., & Picó, Y. (2012). Risk assessment on the presence of pharmaceuticals in
sediments, soils and waters of the Pego-Oliva Marshlands (Valencia, eastern Spain). The Science of the Total
Environment, 440, 24–32. doi:10.1016/j.scitotenv.2012.08.036
Roldán, R. L., Alda, M. L., Gros, M., Petrovic, M., Alonso, J. M., & Barceló, D. (2010). Advanced monitoring of
pharmaceuticals and estrogens in the Llobregat River Basin (Spain) by liquid chromatography-triple
quadrupole-tandem mass spectrometry in combination with ultra performance liquid chromatography-time of
flight-mass spectrometry. Chemosphere, 80(11), 1337–1344. doi:10.1016/j.chemosphere.2010.06.042
Rosal, R., Rodríguez, A., Melón, J. A. P., Petre, A., Calvo, E. G., Gómez, M. J., et al. (2010). Occurrence of
emerging pollutants in urban wastewater and their removal through biological treatment followed by
ozonation. Water Research, 44(2), 578–588. doi:10.1016/j.watres.2009.07.004
Rossmann, J., Schubert, S., Gurke, R., Oertel, R., & Kirch, W. (2014). Simultaneous determination of most
prescribed antibiotics in multiple urban wastewater by SPE-LC-MS/MS. Journal of Chromatography B, 969,
162–170. doi:10.1016/j.jchromb.2014.08.008
Ruff, M., Mueller, M. S., Loos, M., & Singer, H. P. (2015). Quantitative target and systematic non-target analysis of
polar organic micro-pollutants along the river Rhine using high-resolution mass-spectrometry – identification
of unknown sources and compounds. Water Research, 87, 145–154. doi:10.1016/j.watres.2015.09.017
Santos, L. H. M. L. M., Gros, M., Mozaz, S. R., Matos, C. D., Pena, A., Barceló, D., & Montenegro, M. C. B. S. M.
(2013). Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of
ecologically relevant pharmaceuticals. The Science of the Total Environment, 461-462, 302–316.
doi:10.1016/j.scitotenv.2013.04.077
Seifrtová, M., Aufartová, J., Vytlacilová, J., Pena, A., Solich, P., & Nováková, L. (2010). Determination of
fluoroquinolone antibiotics in wastewater using ultra high-performance liquid chromatography with mass
spectrometry and fluorescence detection. Journal of Separation Science, 33(14), 2094–2108.
doi:10.1002/jssc.201000215
Senta, I., Terzic, S., & Ahel, M. (2013). Occurrence and fate of dissolved and particulate antimicrobials in municipal
wastewater treatment. Water Research, 47(2), 705–714. doi:10.1016/j.watres.2012.10.041
Serna, R. L., Pérez, S., Ginebreda, A., Petrović, M., & Barceló, D. (2010). Fully automated determination of 74
pharmaceuticals in environmental and waste waters by online solid phase extraction–liquid chromatography-
electrospray–tandem mass spectrometry. Talanta, 83(2), 410–424. doi:10.1016/j.talanta.2010.09.046
Serna, R. L., Petrović, M., & Barceló, D. (2011). Development of a fast instrumental method for the analysis of
pharmaceuticals in environmental and wastewaters based on ultra high performance liquid chromatography
(UHPLC)-tandem mass spectrometry (MS/MS). Chemosphere, 85(8), 1390–1399.
doi:10.1016/j.chemosphere.2011.07.071
Serna, R. L., Petrović, M., & Barceló, D. (2012). Occurrence and distribution of multi-class pharmaceuticals and their
active metabolites and transformation products in the Ebro river basin (NE Spain). The Science of the Total
Environment, 440, 280–289. doi:10.1016/j.scitotenv.2012.06.027
Sikorska, M. G., Posyniak, A., Sniegocki, T., & Zmudzki, J. (2015). Liquid chromatography-tandem mass
spectrometry multiclass method for the determination of antibiotics residues in water samples from water
supply systems in food-producing animal farms. Chemosphere, 119, 8–15.
doi:10.1016/j.chemosphere.2014.04.105
Silva, B. F., Jelic, A., Serna, R. L., Mozeto, A. A., Petrovic, M., & Barceló, D. (2011). Occurrence and distribution of
pharmaceuticals in surface water, suspended solids and sediments of the Ebro river basin, Spain.
Chemosphere, 85(8), 1331–1339. doi:10.1016/j.chemosphere.2011.07.051
Tamtam, F., Mercier, F., Le Bot, B., Eurin, J., Dinh, Q. T., Clément, M., & Chevreuil, M. (2008). Occurrence and
fate of antibiotics in the Seine River in various hydrological conditions. The Science of the Total Environment,
393(1), 84–95. doi:10.1016/j.scitotenv.2007.12.009
Terzić, S., Senta, I., Ahel, M., Gros, M., Petrović, M., Barceló, D., et al. (2008). Occurrence and fate of emerging
wastewater contaminants in Western Balkan Region. The Science of the Total Environment, 399(1-3), 66–77.
doi:10.1016/j.scitotenv.2008.03.003
Thomas, K. V., & Hilton, M. J. (2004). The occurrence of selected human pharmaceutical compounds in UK
estuaries. Marine Pollution Bulletin, 49(5-6), 436–444. doi:10.1016/j.marpolbul.2004.02.028
Tylová, T., Flieger, M., & Olšovská, J. (2013). Determination of antibiotics in influents and effluents of wastewater-
treatment-plants in the Czech Republic-development and application of the SPE and a UHPLC-ToFMS
method. Analytical Methods, 5(8), 2110–2118. doi:10.1039/c3ay00048f
Valcárcel, Y., Alonso, S. G., Gil, J. L. R., Gil, A., & Catalá, M. (2011). Detection of pharmaceutically active
compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk.
Chemosphere, 84(10), 1336–1348. doi:10.1016/j.chemosphere.2011.05.014
Vergeynst, L., Haeck, A., Wispelaere, P., Langenhove, H., & Demeestere, K. (2015). Multiresidue analysis of
pharmaceuticals in wastewater by liquid chromatography-magnetic sector mass spectrometry: Method quality
assessment and application in a Belgian case study. Chemosphere, 119, S2–S8.
doi:10.1016/j.chemosphere.2014.03.069
Verlicchi, P., Al Aukidy, M., Galletti, A., Petrovic, M., & Barceló, D. (2012). Hospital effluent: Investigation of the
concentrations and distribution of pharmaceuticals and environmental risk assessment. The Science of the Total
Environment, 430, 109–118. doi:10.1016/j.scitotenv.2012.04.055
Verlicchi, P., Al Aukidy, M., Jelic, A., Petrović, M., & Barceló, D. (2014). Comparison of measured and predicted
concentrations of selected pharmaceuticals in wastewater and surface water: A case study of a catchment area
in the Po Valley (Italy). The Science of the Total Environment, 470-471, 844–854.
doi:10.1016/j.scitotenv.2013.10.026
Vieno, N. M., Härkki, H., Tuhkanen, T., & Kronberg, L. (2007). Occurrence of pharmaceuticals in river water and
their elimination in a pilot-scale drinking water treatment plant. Environmental Science & Technology, 41(14),
5077–5084. doi:10.1021/es062720x
Vieno, N. M., Tuhkanen, T., & Kronberg, L. (2006). Analysis of neutral and basic pharmaceuticals in sewage
treatment plants and in recipient rivers using solid phase extraction and liquid chromatography-tandem mass
spectrometry detection. Journal of Chromatography A, 1134(1-2), 101–111.
doi:10.1016/j.chroma.2006.08.077
Vieno, N. M., Tuhkanen, T., & Kronberg, L. (2007). Elimination of pharmaceuticals in sewage treatment plants in
Finland. Water Research, 41(5), 1001–1012. doi:10.1016/j.watres.2006.12.017
Wagil, M., Kumirska, J., Stolte, S., Puckowski, A., Maszkowska, J., Stepnowski, P., & Białk-Bielińska, A. (2014).
Development of sensitive and reliable LC-MS/MS methods for the determination of three fluoroquinolones in
water and fish tissue samples and preliminary environmental risk assessment of their presence in two rivers in
northern Poland. The Science of the Total Environment, 493, 1006–1013. doi:10.1016/j.scitotenv.2014.06.082
Wagil, M., Maszkowska, J., Białk-Bielińska, A., Caban, M., Stepnowski, P., & Kumirska, J. (2015). Determination of
metronidazole residues in water, sediment and fish tissue samples. Chemosphere, 119, S28–S34.
doi:10.1016/j.chemosphere.2013.12.061
Zhang, Z. L., & Zhou, J. L. (2007). Simultaneous determination of various pharmaceutical compounds in water by
solid-phase extraction-liquid chromatography-tandem mass spectrometry. Journal of Chromatography A,
1154(1-2), 205–213. doi:10.1016/j.chroma.2007.03.105
Zorita, S., Mårtensson, L., & Mathiasson, L. (2009). Occurrence and removal of pharmaceuticals in a municipal
sewage treatment system in the south of Sweden. The Science of the Total Environment, 407(8), 2760–2770.
doi:10.1016/j.scitotenv.2008.12.030
Zuccato, E., Castiglioni, S., Bagnati, R., Melis, M., & Fanelli, R. (2010). Source, occurrence and fate of antibiotics in
the Italian aquatic environment. Journal of Hazardous Materials, 179(1-3), 1042–1048.
doi:10.1016/j.jhazmat.2010.03.110
Zuccato, E., Castiglioni, S., & Fanelli, R. (2005). Identification of the pharmaceuticals for human use contaminating
the Italian aquatic environment. Journal of Hazardous Materials, 122(3), 205–209.
doi:10.1016/j.jhazmat.2005.03.001